Benign neoplasm of mouth and pharynx

CD2_BENIGN_MOUTH_PHARYNX

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D10 Cause of death: ICD-10 — D10 2 out of 7 registries used, show all original rules.	4110
4. Check minimum number of events None	4110
5. Include endpoints CD2_BENIGN_LIP CD2_BENIGN_TONGUE CD2_BENIGN_FLOOROFMOUTH CD2_BENIGN_MOUTH_NOS CD2_BENIGN_TONSIL CD2_BENIGN_OROPHA_OTHER CD2_BENIGN_NASOPHARYNX CD2_BENIGN_HYPOPHARYNX CD2_BENIGN_PHARYNX_NOS	4423
6. Filter based on genotype QC (FinnGen only)	4423

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum oris sive pharyngis

NAME	CD2_BENIGN_MOUTH_PHARYNX
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_LIP\|CD2_BENIGN_TONGUE\|CD2_BENIGN_FLOOROFMOUTH\|CD2_BENIGN_MOUTH_NOS\|CD2_BENIGN_TONSIL\|CD2_BENIGN_OROPHA_OTHER\|CD2_BENIGN_NASOPHARYNX\|CD2_BENIGN_HYPOPHARYNX\|CD2_BENIGN_PHARYNX_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of mouth and pharynx based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30467	16198	14066
Only index persons	27451	14935	12516
Unadjusted period prevalence (%)
Whole population	0.43	0.46	0.39
Only index persons	0.52	0.55	0.48
Median age at first event (years)
Whole population	55.34	55.81	54.77
Only index persons	54.50	55.16	53.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4423	2434	1989
Unadjusted period prevalence (%)	0.85	0.83	0.88
Median age at first event (years)	57.13	55.35	59.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3966: Matched controls
39658

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D10.19

ICD-10 Finland

Benign tumor of the tongue UNS

919.7

323.0

413

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

2061.0

323.0

356

D10.39

ICD-10 Finland

Benign tumor in other or unspecified part of oral cavity UNS

5518.9

323.0

496

D10.5

ICD-10 Finland

Benign neoplasm: Other parts of oropharynx

+∞

291.3

276

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

17.8

287.7

465

294

D10.30

ICD-10 Finland

Benign tumor of the mucous membrane of the cheek

563.0

268.6

264

D10.09

ICD-10 Finland

Benign tumor of the lip UNS

+∞

256.0

243

D10.6

ICD-10 Finland

Benign neoplasm: Nasopharynx

849.6

246.6

240

D10.9

ICD-10 Finland

Benign neoplasm: Pharynx, unspecified

2226.7

230.3

221

D10.12

ICD-10 Finland

Bone tumor of the tip of the tongue

924.6

181.8

177

D10.04

ICD-10 Finland

Lower lip tumor in the lower lip mucosa

373.9

180.0

180

ENA10

NOMESCO Finland

Biopsy of pharynx

78.5

171.3

194

EAA10

NOMESCO Finland

Excision of lesion of lip

19.2

169.1

264

147

D10.10

ICD-10 Finland

Benign tumor at the base of the tongue

1660.8

160.5

155

EJB10

NOMESCO Finland

Excision of lesion of apex or body of tongue

40.8

144.7

183

EHA10

NOMESCO Finland

Biopsy of palate

29.3

129.6

177

D10.7

ICD-10 Finland

Benign neoplasm: Hypopharynx

+∞

124.6

119

D10.35

ICD-10 Finland

Benign tumor of the soft palate

1193.5

119.4

116

D10.00

ICD-10 Finland

Upper lip tumor in upper lip on lip lip border

1098.2

110.0

107

D10.2

ICD-10 Finland

Benign neoplasm: Floor of mouth

+∞

101.5

D10.34

ICD-10 Finland

Benign tumor of the hard palate

1003.3

100.6

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

11.2

90.9

177

165

EMA10

NOMESCO Finland

Biopsy of tonsil

42.6

86.5

108

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.0

86.2

375

1012

JDB10

NOMESCO Finland

Percutaneous gastrostomy

10.5

84.0

169

168

UJC01

NOMESCO Finland

Scopy of lower throat

12.2

81.7

152

129

EKA10

NOMESCO Finland

Biopsy of cheek

7.1

79.4

203

300

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

79.4

398

1209

EHB00

NOMESCO Finland

Excision of lesion of palate

58.2

77.2

D10.11

ICD-10 Finland

Benign tumor in the back of the tongue

762.7

76.5

EKB00

NOMESCO Finland

Excision of lesion of cheek

30.2

76.4

103

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.6

73.1

355

1048

D10.01

ICD-10 Finland

Uper lip tumor in the upper lip mucosa

627.9

63.0

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

22.4

62.8

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

9.3

59.0

126

140

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

39.7

58.6

TEA00

NOMESCO Finland

Biopsy of lip

10.3

56.6

114

21049

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Other and unspecified parts of mouth

+∞

56.4

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

54.6

1334

8796

D10.1

ICD-10 Finland

Benign neoplasm: Tongue

269.3

52.2

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

5.9

50.6

147

258

D10.03

ICD-10 Finland

Lower lip tumor in the lower lip at the lip red border

504.2

50.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

49.5

1110

7072

D20

ICPC

Mouth/tongue/lip symptom/complaint

3.5

48.1

238

709

D10.36

ICD-10 Finland

Benign tumor of the uvula

165.3

46.9

A07AA02

ATC

nystatin; oral

2.8

45.5

324

1241

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

34.6

44.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

44.2

1548

11153

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

11.8

43.9

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

43.5

1445

10245

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

44.7

43.2

WX110

NOMESCO Finland

Local anesthesy

1.6

42.2

2574

21258

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

42.0

892

5535

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

27.0

40.7

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

36.9

40.0

GBB00

NOMESCO Finland

Tracheostomy

6.9

39.5

101

150

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

8.5

38.7

103

A02BC02

ATC

pantoprazole; systemic

1.6

38.1

2459

20303

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.9

37.6

238

846

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

37.6

1651

12435

D10.33

ICD-10 Finland

Bone tumor in the gums

370.8

37.1

J01DB01

ATC

cefalexin; oral

1.6

36.3

3104

27278

SXA10

NOMESCO Finland

Epithel biopsy of mouth

6.2

36.0

163

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

35.7

2555

21437

A02BC05

ATC

esomeprazole; systemic

1.6

35.7

1524

11354

D10.0

ICD-10 Finland

Benign neoplasm: Lip

124.5

34.7

21000

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Lip

+∞

34.4

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

9.9

34.0

EMB10

NOMESCO Finland

Tonsillectomy

2.8

33.9

226

831

K13.78

ICD-10 Finland

Other change in the oral mucosa

4.3

33.7

129

308

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

8.4

33.6

130

Kela drug reimbursment

Malignant tumour

2.2

33.0

360

1721

K13.29

ICD-10 Finland

Indefinite leukoplakia

6.2

32.8

148

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

32.7

434

2253

ENB00

NOMESCO Finland

Excision or exploration of lesion of pharynx

32.6

32.2

R13

ICD-10 Finland

Dysphagia

2.4

31.6

288

1262

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

31.5

1091

7667

WF002

NOMESCO Finland

Radical radiotherapy

2.6

30.9

234

926

R01AD09

ATC

mometasone; nasal

1.5

30.9

1597

12300

21010

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Tongue

+∞

30.2

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

21.2

30.0

D10.14

ICD-10 Finland

Lingual tonsil

304.7

29.8

R21

ICPC

Throat symptom/complaint

1.7

29.4

649

4021

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.2

29.2

161

521

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

8.8

28.4

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

8.5

28.2

2100A

ICD-9 Finland

Benign neoplasm of lip, oral cavity and pharynx, Lip

+∞

28.2

J39.2

ICD-10 Finland

Other diseases of pharynx

6.6

28.1

112

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

27.8

360

1847

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

27.7

781

5179

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

3.5

27.5

132

385

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

18.8

26.9

R07.0

ICD-10 Finland

Pain in throat

2.4

26.9

243

1059

A01AB09

ATC

miconazole; local oral

2.0

26.9

349

1792

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.0

26.4

341

1747

ZXA00

NOMESCO Finland

Right side

1.5

26.2

999

7122

EJB20

NOMESCO Finland

Excision of lesion of base of tongue

52.0

26.2

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

5.9

25.9

125

C09.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of tonsil

40.4

25.8

N02BE01

ATC

paracetamol; systemic, rectal

1.5

25.8

3238

29407

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

9.1

25.7

N05CF01

ATC

zopiclone; oral

1.5

25.5

1176

8739

ZXC10

NOMESCO Finland

Use of laser

3.6

25.5

117

330

N02AA05

ATC

oxycodone; systemic

1.7

25.4

542

3310

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.8

25.0

166

609

H02AB06

ATC

prednisolone; systemic

1.4

24.9

1677

13433

EJB40

NOMESCO Finland

Hemiglossectomy

19.6

24.7

D10.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of mouth

251.7

24.7

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.4

24.6

226

993

J37.0

ICD-10 Finland

Chronic laryngitis

2.9

24.0

149

523

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

23.9

2230

18915

EMB00

NOMESCO Finland

Excision of lesion of tonsil or adenoids

67.8

23.8

ECA20

NOMESCO Finland

Biopsy of gingiva

5.1

23.7

148

A02BC03

ATC

lansoprazole; oral

1.5

23.7

1045

7673

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.7

23.2

119

ZXA05

NOMESCO Finland

Left side

1.5

23.0

927

6664

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

18.6

23.0

R01AD08

ATC

fluticasone; nasal

1.5

23.0

981

7142

EJB30

NOMESCO Finland

Excision of lesion of floor of mouth

20.2

23.0

2104A

ICD-9 Finland

Benign neoplasm of lip, oral cavity and pharynx, Other and unspecified parts of mouth

+∞

22.9

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.1

22.9

272

1344

N02AX02

ATC

tramadol; systemic, rectal

1.4

22.6

1513

12035

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.3

22.6

N06AX11

ATC

mirtazapine; oral

1.5

22.4

1113

8354

R4110

NOMESCO Finland

Physiotherapy

1.5

22.3

942

6834

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.4

22.2

111

336

J02AC01

ATC

fluconazole; systemic

1.4

21.7

1343

10506

K02.1

ICD-10 Finland

Caries of dentine

1.4

21.5

1942

16243

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

21.4

1666

13572

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

21.0

1768

14584

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

16.6

20.9

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

20.9

860

6188

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

20.7

736

5126

R03AC02

ATC

salbutamol; inhalant

1.4

20.7

1831

15219

J01CA04

ATC

amoxicillin; systemic

1.4

20.0

2918

26321

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

20.0

1213

9418

8070/3-C01.9

ICD-O-3

Squamous cell carcinoma, NOS, of base of tongue, NOS

23.5

19.9

D10.13

ICD-10 Finland

Benign tumor under the tongue

+∞

19.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

19.7

613

4131

WX002

NOMESCO Finland

Sedation and analgesia

1.5

19.7

704

4906

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.7

19.6

137

521

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

19.5

1907

16049

4381

FHL

Exemption of local change

40.3

19.5

J01FF01

ATC

clindamycin; systemic

1.5

19.4

949

7066

J01AA02

ATC

doxycycline; systemic

1.4

19.3

2863

25793

UJF32

NOMESCO Finland

Coloscopy

1.5

19.3

914

6755

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

19.2

971

7270

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

26.1

19.1

J01DA01

ATC

[U] cefalexin; systemic

1.4

19.1

2243

19418

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

18.9

1807

15122

UDC00

NOMESCO Finland

Ear microscopy

1.9

18.8

271

1444

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

18.8

374

2226

N05BA04

ATC

oxazepam; oral

1.5

18.6

840

6145

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

18.6

271

1451

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.7

18.5

Z01.2

ICD-10 Finland

Dental examination

1.4

18.5

1376

11040

UDQ02

NOMESCO Finland

Direct laryngoscopy

5.5

18.2

100

K11.69

ICD-10 Finland

Mukocele UNS

8.2

18.2

K11.60

ICD-10 Finland

Ranula

12.4

18.1

EDB00

NOMESCO Finland

Partial excision of mandible

14.4

18.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

17.8

436

2758

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

5.1

17.7

108

A02BC01

ATC

omeprazole; systemic

1.4

17.6

967

7338

G47.3

ICD-10 Finland

Sleep apnoea

1.5

17.5

724

5191

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

17.4

1266

10088

E0000UV

ATC

1.4

17.4

1351

10891

EAA30

NOMESCO Finland

Partial excision of lower lip

18.7

17.3

M79.6

ICD-10 Finland

Pain in limb

1.4

17.3

1208

9562

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

17.2

193

933

N03AX16

ATC

pregabalin; oral

1.4

17.2

819

6045

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

17.0

348

2087

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.7

16.9

208

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

17.4

16.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

16.7

697

5000

21070

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Nasopharynx

+∞

16.7

2108A

ICD-9 Finland

Benign neoplasm of lip, oral cavity and pharynx, Hypopharynx

+∞

16.7

EJB00

NOMESCO Finland

Excision of ranula

35.2

16.7

R06.0

ICD-10 Finland

Dyspnoea

1.4

16.5

838

6256

K14.9

ICD-10 Finland

Disease of tongue, unspecified

8.6

16.4

D37.09

ICD-10 Finland

Lip, oral cavity and pharynx

20.1

16.4

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.3

1394

11377

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.8

16.3

102

364

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

16.3

200

1005

UDQ22

NOMESCO Finland

Microlaryngoscopy

5.3

16.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

16.2

271

1524

A01AB04

ATC

amphotericin B; local oral

2.1

16.1

180

868

C13.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of hypopharynx

30.1

16.1

C02.10

ICD-10 Finland

Malignant neoplasm of tip of tongue

30.1

16.1

H02AB07

ATC

prednisone; oral

1.6

16.1

488

3258

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

11.7

16.0

R06AE07

ATC

cetirizine; oral

1.3

16.0

1451

11940

R04.2

ICD-10 Finland

Haemoptysis

2.4

15.9

134

564

S29

ICPC

Skin symptom/complaint other

1.5

15.8

561

3882

ZX095

NOMESCO Finland

Combined chemoradiotherapy

5.5

15.8

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

7.7

15.8

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

15.8

1917

16467

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.3

15.6

147

656

2107A

ICD-9 Finland

Benign neoplasm of lip, oral cavity and pharynx, Nasopharynx

+∞

15.6

21099

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Pharynx unspecified

+∞

15.6

D10.05

ICD-10 Finland

Lower lip tumor in lower lip mucosa and on lip lip border

+∞

15.6

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

15.6

834

6277

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

15.6

1355

11068

EBA00

NOMESCO Finland

Extraction of tooth

1.4

15.5

1075

8466

R03BB04

ATC

tiotropium bromide; inhalant

1.7

15.4

344

2120

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

15.3

156

724

A06AD11

ATC

lactulose; oral

1.6

15.3

478

3214

R06.5

ICD-10 Finland

Mouth breathing

1.7

15.3

298

1762

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

28.7

15.2

C02.9

ICD-10 Finland

Malignant neoplasm: Tongue, unspecified

28.7

15.2

R74

ICPC

Upper respiratory infection acute

1.4

15.2

840

6359

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

15.2

271

1561

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

15.1

332

2031

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

15.1

589

4164

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

15.0

143

642

H02AB04

ATC

methylprednisolone; systemic

1.5

15.0

495

3370

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

14.9

249

1402

K14.61

ICD-10 Finland

Glossodynia

4.6

14.9

112

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

14.9

167

808

J20

ICD-10 Finland

Acute bronchitis

1.7

14.9

313

1894

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

14.7

916

7073

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

21.1

14.6

R53

ICD-10 Finland

Malaise and fatigue

1.4

14.6

665

4845

2101A

ICD-9 Finland

Benign neoplasm of lip, oral cavity and pharynx, Tongue

+∞

14.6

21030

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Floor of mouth

+∞

14.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

14.6

662

4822

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

14.6

848

6470

UJC02

NOMESCO Finland

Rigid oesophagoscopy

5.0

14.5

A02BA02

ATC

ranitidine; systemic

1.4

14.5

664

4841

M03BX02

ATC

tizanidine; oral

1.3

14.5

2130

18691

SXC03

NOMESCO Finland

Other oral or dental procedure

4.2

14.5

129

J01FA09

ATC

clarithromycin; systemic

1.4

14.5

1035

8173

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

14.5

1311

10738

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

14.5

705

5204

WZA90

NOMESCO Finland

Other doctors statement

1.4

14.4

736

5486

S18

ICPC

Laceration/cut

1.3

14.4

1438

11954

K13.20

ICD-10 Finland

Idiopathic leukoplakia

6.6

14.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

14.2

1574

13270

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

9.7

14.2

D07AC01

ATC

betamethasone; topical

1.3

14.1

1141

9181

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

14.1

360

2302

R03BA05

ATC

fluticasone; inhalant

1.5

13.8

570

4067

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

13.8

1093

8761

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

4.4

13.7

113

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

13.7

553

3929

J01MA12

ATC

levofloxacin; systemic

1.4

13.6

615

4469

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

13.6

717

5366

R4190

NOMESCO Finland

Nutritional therapy

2.4

13.6

119

514

C10.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oropharynx

+∞

13.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

13.5

628

4592

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

13.5

453

3092

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.2

13.4

134

617

H65.2

ICD-10 Finland

Chronic serous otitis media

4.0

13.4

135

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

13.3

2392

21447

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.5

13.3

105

429

DQA10

NOMESCO Finland

Biopsy of larynx

5.5

13.3

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

9.1

13.2

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

13.2

1329

11025

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

13.1

2016

17693

J45

ICD-10 Finland

Asthma

1.6

13.0

316

1989

J35.1

ICD-10 Finland

Hypertrophy of tonsils

3.5

13.0

174

DHA10

NOMESCO Finland

Biopsy of cavity of nose

4.3

13.0

110

K11.70

ICD-10 Finland

Hypoptyalism

5.6

13.0

SBB10

NOMESCO Finland

Teeth copy

1.9

12.9

190

1024

C07AB07

ATC

bisoprolol; oral

1.3

12.6

1593

13595

J01FA10

ATC

azithromycin; systemic

1.3

12.6

1913

16723

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

12.6

1183

9699

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.8

12.5

208

1170

R03DC03

ATC

montelukast; oral

1.5

12.4

496

3517

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.1

12.3

220

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

12.3

562

4087

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

12.2

316

2023

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

12.2

253

1526

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

12.2

251

1510

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.4

12.1

104

446

K05.30

ICD-10 Finland

Periodontitis complex

1.5

12.1

394

2670

N05AH04

ATC

quetiapine; oral

1.5

12.1

492

3497

R06AX27

ATC

desloratadine; oral

1.4

12.1

816

6360

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

12.1

193

1073

D83

ICPC

Mouth/tongue/lip disease

5.6

12.0

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

12.0

317

2039

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

12.0

134

647

N06AA09

ATC

amitriptyline; systemic

1.6

12.0

332

2161

C04.1

ICD-10 Finland

Malignant neoplasm: Lateral floor of mouth

21.3

12.0

C04.0

ICD-10 Finland

Malignant neoplasm: Anterior floor of mouth

21.3

12.0

B37.0

ICD-10 Finland

Candidal stomatitis

3.8

12.0

129

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

12.0

559

4086

EJW99

NOMESCO Finland

Other operation on tongue or floor of mouth

46.8

11.9

WX402

NOMESCO Finland

General anaesthesia

1.4

11.8

530

3846

R01AD12

ATC

fluticasone furoate; nasal

1.3

11.8

894

7091

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

11.7

3281

30935

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

11.6

512

3694

C05.0

ICD-10 Finland

Malignant neoplasm: Hard palate

30.1

11.6

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

11.6

684

5208

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

11.6

381

2587

8070/3-C13.9

ICD-O-3

Squamous cell carcinoma, NOS, of hypopharynx, NOS

22.9

11.6

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

11.5

124

592

D07AC13

ATC

mometasone; topical

1.3

11.5

941

7544

N06AB04

ATC

citalopram; systemic

1.4

11.5

695

5315

R03AC03

ATC

terbutaline; inhalant

1.5

11.5

442

3108

K03.66

ICD-10 Finland

Tooth plaque

1.8

11.5

202

1157

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

11.4

772

6013

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

11.3

503

3637

L57.0

ICD-10 Finland

Actinic keratosis

1.6

11.3

305

1973

J35.9

ICD-10 Finland

Chronic disease of tonsils and adenoids, unspecified

11.8

11.3

SBA00

NOMESCO Finland

Microbiological examinations

2.4

11.3

384

TDA90

NOMESCO Finland

Removal wax from ear

3.3

11.3

168

C02.0

ICD-10 Finland

Malignant neoplasm: Dorsal surface of tongue

35.1

11.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

11.2

753

5854

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

4.6

11.2

A98

ICPC

Health maint/preventive medicine

1.5

11.2

3630

34886

EMB30

NOMESCO Finland

Adenotomy

3.4

11.2

158

N05BA01

ATC

diazepam; systemic, rectal

1.5

11.2

437

3078

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

11.2

311

2027

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

12.7

11.1

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

11.1

188

1063

M01AB05

ATC

diclofenac; systemic, rectal

1.3

11.0

2323

20986

R51.80

ICD-10 Finland

Headache

1.5

11.0

443

3137

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.9

11.0

149

783

L17

ICPC

Foot/toe symptom/complaint

1.3

11.0

807

6362

H65.0

ICD-10 Finland

Acute serous otitis media

3.2

10.9

172

ZXA10

NOMESCO Finland

Bilateral

1.4

10.9

595

4469

WZC30

NOMESCO Finland

Teaching

1.5

10.8

423

2982

R42

ICD-10 Finland

Dizziness and giddiness

1.4

10.7

692

5339

N17

ICPC

Vertigo/dizziness

1.5

10.7

349

2364

ENB99

NOMESCO Finland

Other excision of pharynx and adjacent structures

17.8

10.7

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

10.7

898

7213

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.8

10.7

188

1080

UJD02

NOMESCO Finland

Gastroscopy

1.9

10.6

163

893

J01FA06

ATC

roxithromycin; oral

1.3

10.5

1345

11423

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

11.2

10.5

P01AB01

ATC

metronidazole; oral, rectal

1.3

10.5

1294

10940

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

10.5

149

797

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

6.5

10.5

R52.9

ICD-10 Finland

Pain, unspecified

1.6

10.4

263

1676

S04

ICPC

Lump/swelling localized

1.6

10.4

286

1860

C12

ICD-10 Finland

Malignant neoplasm of piriform sinus

+∞

10.4

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

10.4

721

5629

R03BA08

ATC

ciclesonide; inhalant

1.6

10.3

254

1607

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

10.3

824

6567

ENW99

NOMESCO Finland

Other operation on pharynx or adjacent structures

32.6

10.3

R03BA02

ATC

budesonide; inhalant

1.4

10.3

536

3988

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

10.3

195

1144

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

10.3

151

817

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

23.4

10.2

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

10.2

441

3171

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

13.1

10.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

10.1

166

KMAK

NOMESCO Finland

1.2

10.1

1681

14713

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

4.7

10.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

10.1

490

3601

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.0

10.1

198

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

3.6

10.1

119

M54.5

ICD-10 Finland

Low back pain

1.3

10.0

1030

8497

E000001

ATC

1.4

10.0

635

4883

DHB50

NOMESCO Finland

Turbinoplasty

2.4

10.0

358

K12.10

ICD-10 Finland

Stomatitis NOS

5.1

10.0

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

9.9

150

818

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

5.3

9.9

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

2.6

9.9

285

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

9.8

287

1895

8070/3-C04.9

ICD-O-3

Squamous cell carcinoma, NOS, of floor of mouth, NOS

20.1

9.8

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

9.8

288

1909

R03AC13

ATC

formoterol; inhalant

1.8

9.7

152

844

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.2

9.7

457

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.6

986

8124

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.3

9.6

145

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

9.6

334

2295

J05AB11

ATC

valaciclovir; oral

1.4

9.6

401

2865

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

9.6

141

764

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

9.5

436

3169

R05

ICPC

Cough

1.3

9.5

678

5307

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

9.4

257

1668

R52.0

ICD-10 Finland

Acute pain

2.2

9.4

435

WX290

NOMESCO Finland

Other blockade of nerve

1.3

9.4

1336

11451

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

9.4

853

6912

8070/3-C09.0

ICD-O-3

Squamous cell carcinoma, NOS, of tonsillar fossa

17.6

9.4

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.4

9.4

324

EKW99

NOMESCO Finland

Other operation on cheek

+∞

9.4

D10.32

ICD-10 Finland

Bone tumor in the cheek sulcus

+∞

9.4

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.4

1278

10906

EBB10

NOMESCO Finland

Insertion of dental implant

2.8

9.3

205

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.3

740

5884

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

9.3

342

2377

G44.2

ICD-10 Finland

Tension-type headache

1.4

9.3

399

2864

L02

ICPC

Back symptom/complaint

1.6

9.3

260

1699

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.9

9.3

194

N03AX12

ATC

gabapentin; oral

1.4

9.2

482

3583

R05

ICD-10 Finland

Cough

1.3

9.2

604

4665

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.7

9.2

218

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

9.2

573

4393

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.0

9.2

115

586

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.1

764

6121

J38.3

ICD-10 Finland

Other diseases of vocal cords

3.3

9.1

135

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

2.9

9.1

185

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

9.0

207

1285

L43.8

ICD-10 Finland

Other lichen planus

2.5

9.0

270

SPAT1153

SPAT

Removal of sutures

1.3

9.0

1052

8800

C08CA01

ATC

amlodipine; oral

1.3

9.0

1155

9769

4392

FHL

Tongue and / or Mouth resection or excision

36.8

9.0

C00.9

ICD-10 Finland

Malignant neoplasm: Lip, unspecified

36.8

9.0

4461

FHL

Local change biopsy, excision, or cryotherapy

36.8

9.0

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

9.0

594

4594

D07AA02

ATC

hydrocortisone; topical

1.4

9.0

396

2856

XF402

NOMESCO Finland

ECG with work load test

1.5

8.9

357

2524

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.1

8.9

475

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

8.9

271

1808

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.5

8.9

266

J01DA06

ATC

[U] cefuroxime; systemic

1.4

8.9

458

3400

K12.18

ICD-10 Finland

Other forms of stomatitis

4.0

8.8

K13.1

ICD-10 Finland

Cheek and lip biting

4.4

8.8

N06AB03

ATC

fluoxetine; oral

1.4

8.8

387

2787

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

8.8

216

1367

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.7

8.8

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

8.8

300

2057

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.8

1410

12232

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

8.7

324

2259

UKC02

NOMESCO Finland

Cystoscopy

1.4

8.7

508

3850

ZX120

NOMESCO Finland

Intravenous

1.5

8.7

292

1991

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.8

8.7

149

850

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

8.7

1018

8515

N07BA03

ATC

varenicline; oral

1.8

8.7

156

905

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

8.7

265

1770

A03

ICPC

Fever

1.4

8.7

424

3120

D07AB08

ATC

desonide; topical

1.5

8.7

316

2197

S21

ICPC

Skin texture symptom/complaint

1.4

8.7

374

2686

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

8.6

156

907

C03DA01

ATC

spironolactone; oral

1.5

8.6

325

2271

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.1

8.6

447

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

8.5

583

4528

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

9.0

8.5

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

8.5

134

743

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

8.5

739

5945

EJB99

NOMESCO Finland

Other excision on tongue and floor of mouth

20.1

8.5

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

20.1

8.5

M25.5

ICD-10 Finland

Pain in joint

1.3

8.4

875

7203

D06

ICPC

Abdominal pain localized other

1.6

8.4

232

1514

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.4

1458

12740

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

4.7

8.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

8.4

194

1210

D82

ICPC

Teeth/gum disease

1.3

8.4

1045

8799

D18.0

ICD-10 Finland

Haemangioma, any site

2.2

8.4

358

N01

ICPC

Headache

1.5

8.4

272

1843

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

8.3

248

1647

C09CA06

ATC

candesartan; oral

1.3

8.3

658

5222

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

8.3

709

5687

C07AA05

ATC

propranolol; systemic

1.3

8.3

581

4532

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

8.3

241

1593

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

8.2

862

7103

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

8.2

341

2428

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

8.2

132

739

A11

ICPC

Chest pain NOS

1.6

8.2

234

1540

M01AE02

ATC

naproxen; oral, rectal

1.2

8.2

1861

16704

R50.9

ICD-10 Finland

Fever, unspecified

1.4

8.1

411

3040

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

8.1

180

1112

EB1WA

NOMESCO Finland

3.6

8.1

R07.3

ICD-10 Finland

Other chest pain

1.5

8.1

279

1914

M79.1

ICD-10 Finland

Myalgia

1.4

8.1

372

2706

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

8.1

199

1262

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

8.1

722

5824

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

8.1

466

3522

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

8.1

300

2095

H57.1

ICD-10 Finland

Ocular pain

2.0

8.0

456

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.0

942

7868

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

8.0

123

679

M01AH05

ATC

etoricoxib; oral

1.2

8.0

1948

17585

Z72.0

ICD-10 Finland

Tobacco use

2.1

8.0

398

H01

ICPC

Ear pain/earache

1.5

8.0

285

1968

EEA10

NOMESCO Finland

Biopsy of maxilla

10.0

8.0

K11.2

ICD-10 Finland

Sialoadenitis

2.0

8.0

102

525

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

8.0

244

1628

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

5.3

8.0

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.6

8.0

220

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.0

304

2131

C05AA08

ATC

fluocortolone; rectal, topical

1.4

7.9

442

3324

1420

FHL

Laryngomicroscopy

3.8

7.9

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

7.9

158

949

A02BX02

ATC

sucralfate; oral

1.8

7.9

127

711

J01DC02

ATC

cefuroxime; systemic

1.7

7.9

166

1010

D07AD01

ATC

clobetasol; topical

1.4

7.9

471

3583

EBB15

NOMESCO Finland

Insertion of dental implant abutment

3.4

7.9

107

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

7.9

211

1370

R04.0

ICD-10 Finland

Epistaxis

1.6

7.8

209

1353

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.9

7.8

162

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.8

7.8

119

657

H93.1

ICD-10 Finland

Tinnitus

1.6

7.8

199

1277

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

7.8

216

1414

R06AX22

ATC

ebastine; oral

1.3

7.8

502

3866

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

7.8

382

2811

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

7.7

276

1908

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

7.7

192

1219

ED1AA

NOMESCO Finland

Mandipular X-ray examination

4.0

7.7

K30

ICD-10 Finland

Functional dyspepsia

1.4

7.7

307

2171

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

7.7

823

6788

ZXB10

NOMESCO Finland

Medial

3.7

7.7

SPF30

NOMESCO Finland

Soling for prothesis

2.3

7.7

286

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

7.7

423

3176

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

7.4

7.7

J01MA14

ATC

moxifloxacin; systemic

1.5

7.6

269

1855

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

7.6

155

937

R29

ICPC

Respiratory symptom/complaint other

1.6

7.6

184

1163

QA7S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in jaw or lips

11.9

7.6

1290

FHL

Epipharyngoscopy

11.9

7.6

C02.1

ICD-10 Finland

Malignant neoplasm: Border of tongue

25.0

7.6

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

7.6

590

4670

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

7.5

482

3703

R49.09

ICD-10 Finland

Unspecified dysphonia

3.1

7.5

122

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.5

7.5

227

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

7.5

205

1334

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

7.5

497

D02

ICPC

Abdominal pain epigastric

1.6

7.5

173

1080

J05AB01

ATC

aciclovir; systemic

1.3

7.4

629

5036

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.7

7.4

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

7.4

187

1195

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

7.4

142

841

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

7.4

156

954

D01

ICPC

Abdominal pain/cramps general

1.4

7.3

295

2092

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

7.3

205

1343

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

7.3

232

1565

J35.2

ICD-10 Finland

Hypertrophy of adenoids

2.8

7.3

152

J33.8

ICD-10 Finland

Other polyp of sinus

2.2

7.3

313

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

7.3

177

1121

21050

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Tonsil

+∞

7.3

2106A

ICD-9 Finland

Benign neoplasm of lip, oral cavity and pharynx, Other parts of oropharynx

+∞

7.3

C05.9

ICD-10 Finland

Malignant neoplasm: Palate, unspecified

+∞

7.3

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

7.3

184

1179

XQ800

NOMESCO Finland

Prick test

1.5

7.2

213

1413

JN6AD

NOMESCO Finland

CT of torso and neck

2.8

7.2

160

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

7.2

457

3507

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

7.2

373

2769

Z50.5

ICD-10 Finland

Speech therapy

2.8

7.2

154

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

7.2

232

1569

C13.9

ICD-10 Finland

Malignant neoplasm: Hypopharynx, unspecified

15.8

7.2

2121A

ICD-9 Finland

Benign neoplasm of respiratory and intrathoracic organs, Larynx

15.8

7.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

7.2

223

1497

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.2

7.2

110

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.8

7.2

121

691

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

7.2

457

3513

8070/3-C06.0

ICD-O-3

Squamous cell carcinoma, NOS, of cheeck mucosa

30.1

7.1

4399

FHL

Other measure in this category

30.1

7.1

C10.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of oropharynx

30.1

7.1

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.9

7.1

484

A01AB10

ATC

natamycin; local oral

2.0

7.1

407

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.1

542

4277

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.6

7.1

185

1192

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

7.1

561

4451

S82

ICPC

Naevus/mole

1.4

7.1

351

2589

K13.2

ICD-10 Finland

Leukoplakia and other disturbances of oral epithelium, including tongue

5.3

7.1

R51.81

ICD-10 Finland

Facial pain NOS

2.2

7.1

327

J35.8

ICD-10 Finland

Other chronic diseases of tonsils and adenoids

5.6

7.0

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

7.0

156

966

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.0

292

2083

F29

ICPC

Eye symptom/complaint other

1.5

7.0

235

1605

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

7.0

293

2096

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

7.0

290

2068

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

7.0

360

2671

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

7.0

106

585

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

7.0

184

1192

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.6

6.9

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.5

6.9

194

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.2

6.9

278

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

6.9

318

2311

K13.03

ICD-10 Finland

Keilit UNS

6.3

6.9

B37.08

ICD-10 Finland

Other candidal stomatitis

3.3

6.9

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.9

367

2737

A01

ICPC

Pain general/multiple sites

1.5

6.9

224

1520

SPAT1301

SPAT

No procedures

1.2

6.9

998

8515

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.9

180

1162

EFA10

NOMESCO Finland

Excision of lesion of jaws

13.8

6.9

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.7

6.8

A04AA01

ATC

ondansetron; systemic, rectal

1.5

6.8

192

1263

R11

ICD-10 Finland

Nausea and vomiting

1.5

6.8

223

1514

J45.8

ICD-10 Finland

Mixed asthma

1.9

6.8

466

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

6.8

266

1876

JN4BD

NOMESCO Finland

Extensive body CT

1.4

6.8

346

2562

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.5

6.8

197

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

6.8

149

921

EJC00

NOMESCO Finland

Suture of tongue or floor of mouth

10.9

6.8

C10AA01

ATC

simvastatin; oral

1.2

6.8

1400

12377

EHW99

NOMESCO Finland

Other operation on palate

40.1

6.8

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

6.8

302

2184

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.7

350

2600

C03CA01

ATC

furosemide; systemic

1.2

6.7

874

7365

C04.9

ICD-10 Finland

Malignant neoplasm: Floor of mouth, unspecified

16.7

6.7

J01AA07

ATC

tetracycline; systemic

1.3

6.7

417

3193

L01

ICPC

Neck symptom/complaint

1.4

6.7

399

3034

N06AX21

ATC

duloxetine; oral

1.4

6.7

305

2216

ENB20

NOMESCO Finland

Pharyngectomy

22.5

6.7

L08

ICPC

Shoulder symptom/complaint

1.3

6.7

574

4604

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

6.6

258

1818

R49.08

ICD-10 Finland

Other specified dysphonia

2.2

6.6

304

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

6.6

361

2707

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

5.5

6.6

WX722

NOMESCO Finland

PEEP

1.7

6.6

138

840

SPAT1260

SPAT

Consultation of another employee

1.3

6.6

541

4310

DHB10

NOMESCO Finland

Excision of lesion of internal nose

4.6

6.6

A01AC01

ATC

triamcinolone; local oral

2.3

6.5

246

K14.88

ICD-10 Finland

Other diseases of tongue

10.0

6.5

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.7

6.5

158

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

6.5

385

2928

C83.1

ICD-10 Finland

Mantle cell lymphoma

4.5

6.5

K02.2

ICD-10 Finland

Caries of cementum

1.7

6.4

125

747

R02

ICPC

Shortness of breath/dyspnoea

1.4

6.4

348

2605

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

70.0

6.4

G04CA02

ATC

tamsulosin; oral

1.3

6.4

661

5420

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

6.4

488

3846

B01AB05

ATC

enoxaparin; parenteral

1.2

6.4

969

8298

R60.0

ICD-10 Finland

Localized oedema

1.4

6.4

320

2362

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

6.4

501

3966

K14.60

ICD-10 Finland

Glossopyrosis

4.1

6.4

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

6.4

290

2108

N05CD07

ATC

temazepam; oral

1.3

6.4

378

2871

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.4

793

6652

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

6.3

283

2048

L20.0

ICD-10 Finland

Besnier prurigo

1.6

6.3

152

962

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.3

201

1360

WW200

NOMESCO Finland

Immunization

1.9

6.3

453

ENC30

NOMESCO Finland

Plastic operation of pharynx

2.5

6.3

180

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

9.3

6.3

4322

FHL

Partial mucosal removal or cryo (biopsy, tumor, hyperplasty)

18.0

6.3

K07.60

ICD-10 Finland

Snapping jaw

1.7

6.3

130

792

4509

FHL

Other measure in this category

+∞

6.2

D10.37

ICD-10 Finland

Benign tumor in the retromolar area

+∞

6.2

21068

ICD-8 Finland

Benign neoplasm of buccal cavity and pharynx, Other parts of oropharynx

+∞

6.2

C13.1

ICD-10 Finland

Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect

+∞

6.2

D10.38

ICD-10 Finland

Benign tumor in maxilla tubes

+∞

6.2

H92.0

ICD-10 Finland

Otalgia

1.6

6.2

135

832

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

6.2

353

2661

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

6.2

406

3133

A02BC04

ATC

rabeprazole; oral

1.4

6.2

245

1736

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.2

6.2

285

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

6.2

144

907

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.5

6.1

D02AE01

ATC

carbamide; topical

1.5

6.1

197

1335

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.6

6.1

152

A04AA02

ATC

granisetron; systemic, transdermal

1.5

6.1

185

1238

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

4.7

6.1

N06AB10

ATC

escitalopram; oral

1.3

6.1

555

4483

M48.0

ICD-10 Finland

Spinal stenosis

1.3

6.1

362

2754

R03BA01

ATC

beclometasone; inhalant

1.3

6.1

410

3178

UDM02

NOMESCO Finland

Sinoscopy

2.0

6.0

325

EEB00

NOMESCO Finland

Partial excision of maxilla

8.6

6.0

A02BA03

ATC

famotidine; systemic

1.7

6.0

116

692

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

6.0

114

675

SXC05

NOMESCO Finland

Other oral or dental procedure

1.6

6.0

160

1041

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.0

544

4390

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

2413

14816

2.38

170.63

2.6

2.1

—

(4035726)

631

3281

2.08

56.48

1.5

1.4

—

(3013115) Eosinophils [#/volume] in Blood

2419

18847

1.63

52.97

7.1

6.0

e9/l

0.2

0.24

2125

16505

(3013650) Neutrophils [#/volume] in Blood by Automated count

2642

21143

1.62

50.91

10.8

9.1

e9/l

4.1

0.18

2309

18414

(3006315) Basophils [#/volume] in Blood

2343

18226

1.61

50.70

6.8

5.9

e9/l

0.0

0.05

2034

15710

(3001604) Monocytes [#/volume] in Blood

2333

18149

1.60

50.32

6.8

5.8

e9/l

0.6

0.06

2027

15640

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2364

18487

1.60

49.56

7.2

6.8

mmol/l

1.2

0.24

1976

15632

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3331

28364

1.71

49.25

9.1

7.6

u/l

78.8

78.6

0.12

3148

26719

(42870588) Differential panel, method unspecified - Blood

1718

12482

1.62

48.82

6.6

5.9

—

(3019198) Lymphocytes [#/volume] in Blood

2376

18652

1.59

48.62

6.8

5.9

e9/l

1.9

0.80

2103

16387

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2177

16787

1.58

47.76

6.4

6.0

mmol/l

1.2

0.10

1943

15219

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2427

19205

1.58

47.53

6.9

6.2

umol/l

11.2

11.5

0.35

2302

18227

(3006504) Eosinophils/100 leukocytes in Blood

2199

17050

1.58

46.71

7.0

6.1

2.8

2.9

0.46

2031

15859

(3019069) Monocytes/100 leukocytes in Blood

2207

17145

1.57

46.35

7.3

6.4

8.7

0.09

2047

16024

(3022096) Basophils/100 leukocytes in Blood

2147

16575

1.57

46.33

7.1

6.1

0.7

0.14

1982

15433

(3024561) Albumin [Mass/volume] in Serum or Plasma

2080

15961

1.57

45.95

5.3

4.9

g/l

35.5

35.4

0.29

1940

14851

(3002030) Lymphocytes/100 leukocytes in Blood

2240

17594

1.55

43.84

7.2

6.2

27.0

27.7

2.11

2069

16350

(3012095) Magnesium [Moles/volume] in Serum or Plasma

944

6054

1.71

42.66

4.4

3.3

mmol/l

0.8

4.17

880

5643

(3018010) Neutrophils/100 leukocytes in Blood

2205

17340

1.54

42.34

6.9

6.0

58.1

57.3

2.03

2044

16180

(3013707) Erythrocyte sedimentation rate by Westergren method

3161

27007

1.60

41.28

4.8

4.1

mm/h

12.9

12.5

0.98

2897

24997

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

233

925

2.60

38.84

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1657

12466

1.53

37.60

4.0

3.4

mmol/l

2.4

0.99

1425

10859

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1932

15076

1.50

36.47

2.2

2.0

pmol/l

94.0

95.5

0.70

964

7789

(3037467) Urinalysis macro (dipstick) panel - Urine

2945

25067

1.52

36.22

5.0

4.4

—

(3033658) Prothrombin time (PT) actual/Normal

1302

9395

1.55

35.29

4.3

4.0

90.7

89.7

0.67

1270

9158

(3013826) Glucose [Moles/volume] in Serum or Plasma

2599

21624

1.49

35.14

5.3

4.7

mmol/l

6.7

0.02

2464

20270

(3000494) Fungus identified in Specimen by Culture

699

4336

1.73

34.94

1.6

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2826

24038

1.49

33.28

5.2

4.5

e6/l

1706.2

1552.7

0.05

332

(3018418) pH of Serum or Plasma

1469

11004

1.50

32.90

4.6

4.0

7.4

0.98

250

2104

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

918

6242

1.59

31.76

2.9

2.7

e6/l

1.0

1.1

0.38

515

3568

(40758558) Short blood count panel - Blood

1275

9348

1.51

31.34

8.0

6.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3166

27721

1.50

30.96

4.7

4.0

pmol/l

14.8

0.06

2852

25167

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3669

33192

1.62

30.82

5.7

4.8

mu/l

1.9

2.1

1.49

3340

30329

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3934

36277

1.76

30.26

19.9

14.5

mg/l

23.9

24.1

0.14

3323

28896

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

845

5698

1.60

30.09

1.6

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1359

10165

1.49

30.03

3.6

3.2

e6/l

0.3

0.4

1.24

1008

7685

(3023368) Bacteria identified in Blood by Culture

1348

10071

1.49

29.95

4.9

4.3

—

(3018095) Leukocytes [#/volume] in Urine

1660

12916

1.46

29.94

4.2

3.7

e6/l

58.9

107.5

3.26

1185

9175

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

858

5814

1.59

29.91

3.1

2.9

e6/l

2.2

2.5

0.71

460

3166

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1879

15038

1.43

28.77

2.4

2.2

nmol/l

77.1

78.0

0.70

1649

13491

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

659

4235

1.65

28.38

4.4

4.2

u/l

234.0

244.6

0.95

612

3996

(3019550) Sodium [Moles/volume] in Serum or Plasma

4028

37518

1.82

28.34

21.8

16.7

mmol/l

139.5

139.7

4.94

3937

36612

(3002582) Erythrocytes [#/volume] in Urine

1446

11060

1.46

28.08

3.6

3.3

e6/l

80.7

91.7

0.08

1103

8512

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

653

4208

1.65

27.78

2.9

2.7

umol/l

8.2

8.3

0.06

573

3668

(3042936) Bacteria identified in Isolate by Culture

769

5176

1.59

27.33

2.2

2.1

—

(3032080) INR in Blood by Coagulation assay

1868

15034

1.42

27.23

9.0

9.3

inr

1.2

1.3

1.36

476

4288

(3023103) Potassium [Moles/volume] in Serum or Plasma

4031

37629

1.80

27.10

22.1

16.8

mmol/l

4.0

3.50

3932

36667

(3009542) Hematocrit [Volume Fraction] of Blood

3612

32814

1.55

26.98

20.8

15.5

39.7

0.20

2513

23260

(3007853) Bacteria identified in Skin by Aerobe culture

654

4249

1.63

26.87

2.1

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

1502

11684

1.43

26.19

2.8

2.4

—

(36304419) Bacteria [Presence] in Urine

1305

9895

1.45

26.12

3.6

3.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

547

3461

1.66

24.82

2.7

2.4

u/l

35.2

52.0

0.64

456

2981

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

943

6765

1.50

24.80

3.4

3.0

mmol/l

2.5

0.98

825

5930

(40768797) Stomach Pathology biopsy report

747

5127

1.55

24.09

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

127

477

2.71

23.69

1.6

1.3

—

(3002256) Pathology report gross observation

707

4820

1.56

23.44

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

201

938

2.20

23.31

3.4

3.1

mg/l

1.3

1.6

4.12

189

856

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1184

8969

1.44

23.30

2.6

2.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3721

34303

1.53

23.11

18.1

13.6

ml/min/173m2

80.7

80.1

1.09

3143

28395

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

846

6019

1.50

22.95

2.0

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2050

17194

1.36

21.42

4.2

4.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3793

35248

1.53

21.25

5.1

4.6

mmol/l

6.0

1.87

3419

32104

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1491

11904

1.38

21.23

3.5

3.2

u/l

30.5

36.6

2.90

1410

11294

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

539

3530

1.60

21.11

2.6

2.2

g/l

0.2

2.11

507

3285

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1844

15266

1.36

20.73

3.2

2.8

ug/l

136.0

131.5

0.29

1671

14099

(3026782) Osmolality of Urine

964

7192

1.44

20.16

3.2

2.8

mosm/kgh2o

534.5

545.5

0.81

796

6124

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2699

23789

1.35

19.44

3.4

3.1

u/l

52.1

50.0

0.39

2493

22113

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1046

7976

1.41

19.22

1.7

1.8

mg/l

1.2

0.14

800

6097

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2505

21878

1.33

18.96

3.1

2.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1436

11575

1.36

18.66

2.9

2.6

u/l

57.2

57.9

0.22

1311

10696

(3003458) Phosphate [Moles/volume] in Serum or Plasma

686

4861

1.49

18.62

6.2

5.9

mmol/l

1.0

0.62

629

4525

(40761511) CBC panel - Blood by Automated count

3985

37692

1.58

17.88

17.3

13.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

682

4865

1.48

17.84

25.8

25.0

inr

1.3

1.4

0.72

691

(3019309) Folate [Moles/volume] in Red Blood Cells

914

6887

1.41

17.79

1.9

1.8

nmol/l

1170.4

1168.9

0.01

632

5198

(3021960) Folate [Moles/volume] in Serum or Plasma

1099

8545

1.38

17.76

1.7

1.5

nmol/l

20.7

20.6

0.04

922

7307

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

596

4150

1.50

17.55

1.9

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

737

5355

1.45

17.50

2.6

2.5

g/l

2.3

0.18

673

4961

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4065

38662

1.64

17.44

13.2

10.6

u/l

26.6

26.4

0.24

3931

37298

(3014111) Lactate [Moles/volume] in Serum or Plasma

481

3210

1.56

17.23

6.6

6.9

mmol/l

1.4

0.36

458

3099

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

415

2682

1.60

17.05

1.8

1.6

—

(3013512) EKG study

1340

10806

1.34

17.00

4.3

3.9

—

(3000850) Epithelial cells [#/volume] in Urine

1003

7745

1.38

16.76

2.9

2.6

e6/l

5.1

5.4

0.39

855

6782

(3036481) Cortisol [Moles/volume] in Serum or Plasma

494

3338

1.54

16.71

2.7

2.2

nmol/l

374.8

371.2

0.16

439

3065

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1387

11265

1.34

16.71

2.3

2.2

u/l

168.9

231.3

2.92

1294

10566

(3000492) Spirometry study

503

3430

1.53

16.30

1.6

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1077

8450

1.36

16.21

3.9

3.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

686

4988

1.44

16.12

2.6

22.3

22.9

0.53

589

4266

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1166

9269

1.35

16.10

2.5

2.2

mg/l

2.9

3.0

0.60

977

7928

(40768443) Skin Pathology biopsy report

273

1606

1.75

16.06

1.2

—

(3000991) Gas panel - Venous blood

453

3030

1.55

16.02

7.9

8.3

—

(3044889) 12 lead EKG panel

2861

25755

1.31

15.98

4.3

3.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

258

2.90

15.98

1.3

—

(4010399)

397

2580

1.59

15.92

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

587

4156

1.48

15.83

1.9

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

777

5800

1.41

15.75

2.6

2.5

umol/l

12.9

13.1

0.38

710

5388

(3027945) Reticulocytes/100 erythrocytes in Blood

588

4176

1.47

15.59

2.6

2.4

1.8

0.35

497

3699

(3007164) IgA [Mass/volume] in Serum or Plasma

887

6786

1.38

15.53

1.7

1.4

g/l

2.4

2.5

0.26

511

4091

(3024731) MCV [Entitic volume]

4183

40223

1.74

15.38

28.2

21.3

91.2

91.1

0.52

4126

39638

(3026361) Erythrocytes [#/volume] in Blood

4183

40228

1.73

15.31

28.3

21.4

e12/l

4.5

3.87

4067

39086

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

318

1976

1.66

15.28

8.2

9.3

mmol/l

24.7

24.4

1.12

300

1845

(3026493) Urate [Moles/volume] in Serum or Plasma

1206

9698

1.33

15.27

2.9

2.6

umol/l

4132.4

4726.2

0.21

1026

8433

(3010813) Leukocytes [#/volume] in Blood

4183

40235

1.73

15.20

28.4

21.4

e9/l

6.9

6.7

1.75

4065

39084

(3000963) Hemoglobin [Mass/volume] in Blood

4183

40237

1.73

15.17

28.5

21.5

g/l

134.1

135.3

5.86

4124

39653

(3035941) MCH [Entitic mass]

4182

40225

1.73

15.17

28.2

21.3

30.3

0.02

4126

39637

(3021589) Normoblasts [#/volume] in Blood

1880

16099

1.29

14.93

11.4

9.6

e9/l

0.0

1.04

1538

13175

(3007461) Platelets [#/volume] in Blood

4179

40206

1.71

14.90

28.3

21.4

e9/l

250.8

250.1

0.27

4083

39178

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

926

7178

1.37

14.87

4.3

3.7

ng/l

262.7

557.9

1.31

727

5659

(3009445) Proteinase 3 Ab [Units/volume] in Serum

257

1531

1.72

14.47

1.5

u/ml

8.1

18.3

—

(3015736) pH of Urine

1633

13776

1.29

14.40

3.8

3.4

—

5.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3588

33551

1.37

14.34

6.5

5.8

mmol/mol

40.2

39.9

1.01

3283

31017

(3005719) IgG [Mass/volume] in Serum or Plasma

409

2761

1.53

13.83

3.0

2.6

g/l

10.4

10.5

0.09

377

2511

(3026008) Bacteria identified in Urine by Culture

1336

11037

1.30

13.63

3.4

3.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

632

4658

1.42

13.63

7.6

6.9

mmol/l

104.1

104.3

0.54

620

4553

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

971

7679

1.34

13.51

1.3

u/ml

1.4

1.8

0.70

229

1999

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1297

10683

1.30

13.50

3.0

ng/l

1494.5

1427.2

0.21

1112

9155

(3017143) Hepatitis C virus Ab [Presence] in Serum

536

3849

1.45

13.32

1.6

—

(40768795) Lymph node Pathology biopsy report

363

2.42

13.23

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2032

17755

1.27

13.10

5.6

5.0

estimate

0.0

0.50

343

3344

(3009261) Glucose [Presence] in Urine by Test strip

2051

17963

1.26

12.88

4.2

3.7

estimate

0.0

1.57

332

3254

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3848

36542

1.41

12.80

5.4

5.0

mmol/l

2.7

0.04

3477

33632

(3018677) aPTT in Platelet poor plasma by Coagulation assay

748

5742

1.36

12.56

2.2

2.1

30.1

29.8

0.48

727

5573

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1646

14079

1.27

12.48

4.1

3.7

ng/l

29.6

85.1

1.04

1149

9780

(3035350) Ketones [Presence] in Urine by Test strip

2022

17729

1.26

12.40

4.1

3.7

estimate

0.0

0.50

336

3293

(3023520) Reticulocytes [#/volume] in Blood

443

3112

1.47

12.32

2.8

2.5

e9/l

71.4

69.8

0.43

310

2358

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

617

4604

1.40

12.31

8.1

7.0

—

(3002032) Base excess in Venous blood by calculation

472

3365

1.45

12.15

3.8

3.7

mmol/l

2.1

2.0

0.38

399

2729

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

159

3.11

12.07

3.3

2.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

472

3376

1.45

11.94

3.8

3.6

kpa

5.8

0.10

460

3277

(3005322) IgE [Units/volume] in Serum or Plasma

324

2155

1.54

11.71

1.4

1.3

u/ml

233.8

212.4

0.16

303

1985

(3004588) Protein electrophoresis panel - Serum or Plasma

375

2585

1.49

11.45

2.8

2.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

204

1219

1.71

11.40

1.7

1.6

titre

690.6

357.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3773

35844

1.36

11.38

4.9

4.5

mmol/l

4.6

4.7

1.10

3432

33177

(3002385) Erythrocyte distribution width [Ratio]

3215

29904

1.27

11.25

23.5

17.6

13.8

13.7

3.24

3160

29248

(3052851) Hemolysis interference index of Serum or Plasma

188

1104

1.73

11.19

3.2

3.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

363

2498

1.49

11.18

1.4

—

(3022145) Colonoscopy Study observation

552

4117

1.39

10.99

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

564

4223

1.38

10.96

2.5

2.3

ug/g

133.7

142.5

0.19

435

3334

(46235355) HIV 1 and 2 tests - Meaningful Use set

708

5502

1.34

10.85

1.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

204

1236

1.68

10.84

2.6

2.7

—

(3019225) pH of Specimen

508

3755

1.40

10.65

4.1

4.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

327

2226

1.51

10.61

1.8

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

319

2168

1.51

10.44

2.3

1.8

g/l

1.7

1.4

0.53

287

1970

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3740

35579

1.33

10.42

4.8

4.4

mmol/l

1.4

1.5

3.39

3367

32730

(3020630) Protein [Mass/volume] in Serum or Plasma

429

3103

1.42

10.18

3.6

2.6

g/l

66.3

66.4

0.10

383

2841

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1461

1.61

10.16

3.1

2.4

g/l

7.6

7.4

0.64

164

1114

(3008295) Osmolality of Serum or Plasma

390

2.18

10.06

1.5

1.4

mosm/kgh2o

284.1

278.2

1.59

306

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

477

2.06

10.02

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

1459

1.60

10.00

3.1

2.4

g/l

3.8

0.10

159

1065

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

1460

1.60

9.97

3.1

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

550

4164

1.37

9.95

1.8

1.5

0.53

463

3666

(3003338) MCHC [Mass/volume]

3254

30469

1.26

9.87

24.8

18.6

g/l

331.9

332.3

1.87

3228

30243

(3037522) Nuclear Ab [Titer] in Serum

623

4818

1.34

9.80

1.4

1.3

titre

576.2

526.8

0.23

126

1002

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

257

1691

1.55

9.77

1.5

1.7

g/l

1.6

1.5

0.04

209

1451

(3020779) Urea [Moles/volume] in Serum or Plasma

454

3340

1.40

9.77

7.0

7.6

mmol/l

8.8

9.9

3.30

428

3184

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3622

34373

1.30

9.76

4.3

4.0

mmol/l

1.3

3.31

3238

31371

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1369

1.61

9.65

3.0

2.4

g/l

3.1

0.03

159

1090

(3025941) Bacteria identified in Stool by Culture

291

1976

1.51

9.57

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

263

1750

1.53

9.51

3.8

3.9

mmol/l

24.9

24.2

2.87

236

1582

(3003396) Base excess in Arterial blood by calculation

562

4302

1.35

9.45

7.0

7.3

mmol/l

1.0

1.1

0.26

450

3340

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

162

960

1.71

9.39

1.7

1.4

iu/ml

10.2

19.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

148

860

1.75

9.21

1.4

u/l

11.7

10.0

0.64

123

697

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1358

1.59

9.08

3.0

2.4

g/l

10.4

10.3

0.05

171

1167

(3024354) Oxygen [Partial pressure] in Venous blood

382

2764

1.42

9.04

3.2

3.0

kpa

4.6

0.09

370

2674

(3013139) Helicobacter pylori Ag [Presence] in Stool

339

2407

1.44

8.90

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

308

2149

1.47

8.86

3.5

3.3

pmol/l

4.4

0.12

269

1906

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

139

803

1.75

8.84

1.3

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

171

1048

1.66

8.76

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

558

4321

1.33

8.66

7.1

7.3

kpa

5.1

0.41

531

4113

(3027801) Oxygen [Partial pressure] in Arterial blood

558

4321

1.33

8.66

7.1

7.3

kpa

12.4

12.3

0.24

529

4113

(3037756) Immunofixation for Serum or Plasma

134

774

1.75

8.54

1.8

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

950

7898

1.26

8.53

5.0

4.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

284

1966

1.48

8.52

2.5

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

171

1057

1.64

8.49

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

124

703

1.79

8.43

1.2

titre

32.0

233.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

174

1087

1.63

8.29

1.6

1.4

ug/g

298.6

279.6

0.20

108

625

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

303

2136

1.45

8.28

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

167

1038

1.63

8.12

1.2

—

(3021788) Differential panel - Synovial fluid

116

655

1.79

8.01

1.7

1.5

—

(3045414) Leukocytes [Presence] in Urine

242

1649

1.49

7.87

1.9

2.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

399

2978

1.37

7.86

2.9

2.7

ml/min/173m2

67.5

65.2

0.54

169

1183

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

328

2373

1.41

7.78

8.6

8.8

1.4

1.3

0.11

322

2358

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

593

4703

1.30

7.73

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

179

1149

1.58

7.65

2.7

2.2

g/l

37.2

37.6

0.33

146

998

(3035637) Corticotropin [Mass/volume] in Plasma

435

1.95

7.61

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

559

1.83

7.47

2.6

u/ml

54690.0

1864.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

102

569

1.81

7.36

2.0

1.6

g/l

0.8

0.15

428

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

122

720

1.71

7.26

4.4

5.3

iu/ml

560.7

639.1

0.07

105

(3003327) Ova and parasites identified in Stool by Light microscopy

169

1086

1.58

7.21

1.8

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

190

1254

1.54

7.20

3.1

2.4

g/l

1.2

1.0

0.24

160

1093

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

503

3944

1.31

7.12

3.5

4.0

ug/l

11.0

25.6

1.80

403

3192

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

157

1001

1.59

6.94

2.2

2.6

185.0

192.9

0.46

148

957

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

206

1398

1.50

6.87

1.1

u/ml

1.0

1.3

—

(3016502) Oxygen saturation in Arterial blood

492

3869

1.31

6.81

7.4

7.7

95.8

95.7

0.26

473

3724

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

124

749

1.67

6.80

1.2

u/ml

1.4

3.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

127

776

1.66

6.67

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

127

776

1.66

6.67

1.5

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

141

887

1.61

6.60

1.7

1.6

e6/l

11442.0

13550.2

0.34

105

636

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

155

998

1.57

6.59

1.3

1.2

u/ml

23.5

42.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

148

943

1.59

6.58

2.0

1.9

mg/l

11.8

11.3

0.37

135

872

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

159

1032

1.56

6.53

2.8

2.3

g/l

0.0

0.72

142

953

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

168

1105

1.54

6.50

2.9

2.3

g/l

0.1

0.0

0.88

151

1020

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

157

1019

1.56

6.45

2.8

2.3

g/l

0.0

0.00

142

952

(3021387) Prolactin [Units/volume] in Serum or Plasma

158

1027

1.56

6.45

1.7

1.6

mu/l

310.9

297.5

0.22

146

929

(36660697) Celiac disease serology panel - Serum

363

2756

1.35

6.43

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1253

10990

1.20

6.40

3.6

3.3

mg/l

461.9

313.2

0.51

819

6929

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

732

6090

1.24

6.37

1.3

iu/ml

30.0

33.7

0.39

207

1905

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

219

1532

1.45

6.29

2.0

1.9

u/l

41.6

38.9

1.25

192

1351

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

160

1051

1.54

6.25

2.1

1.6

g/l

0.2

0.01

152

990

(3039162) Centromere protein B Ab [Units/volume] in Serum

437

1.85

6.24

1.2

1.3

u/ml

42.0

49.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

119

729

1.65

6.22

1.3

1.2

u/ml

33.4

45.2

0.65

(3009508) Creatinine [Moles/volume] in Urine

1314

11601

1.19

6.19

3.6

3.2

mmol/l

7.5

0.16

1098

9757

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

374

1.91

6.19

4.1

3.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

418

1.86

6.13

1.3

1.4

u/l

24.2

29.4

0.74

341

(3003181) Sodium [Moles/volume] in Urine

108

648

1.68

6.12

1.5

1.3

mmol/l

58.1

62.1

0.46

525

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

144

930

1.57

6.07

1.3

u/ml

4.5

7.8

0.87

155

(3004716) Salmonella sp identified in Stool by Organism specific culture

238

1704

1.42

6.04

1.5

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

921

7886

1.21

6.04

1.8

1.7

pmol/l

29589486.4

31786797.6

0.04

730

6572

(3014051) Protein [Presence] in Urine by Test strip

133

847

1.59

5.96

2.2

2.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

190

1313

1.47

5.84

2.2

2.3

ug/l

371.7

664.4

0.95

178

1237

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

305

2290

1.36

5.83

1.2

iu/ml

151.0

149.1

0.03

102

830

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

150

988

1.54

5.81

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

367

2834

1.32

5.81

3.9

ng/l

87.6

90.5

0.24

313

2433

(40761535) Cells panel - Urine sediment

392

3064

1.31

5.68

3.7

3.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

693

5802

1.23

5.65

1.3

u/ml

11.3

11.0

0.03

213

2249

(3010375) cycloSPORINE [Mass/volume] in Blood

157

2.37

5.63

26.0

24.7

ug/l

102.9

113.1

0.64

128

(3017732) Neutrophils [#/volume] in Blood

331

2533

1.33

5.58

2.8

3.0

e9/l

4.1

4.2

0.30

220

1985

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

140

917

1.54

5.58

1.3

1.2

u/ml

3.1

6.3

0.44

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

218

1560

1.42

5.57

2.1

1.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

294

2211

1.35

5.57

3.4

3.1

g/l

129.2

128.7

0.14

287

2145

(3020682) Albumin/Creatinine [Ratio] in Urine

1300

11556

1.18

5.54

4.5

4.0

mg/mmol

12.5

9.4

0.65

832

7289

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

307

2332

1.34

5.45

4.0

3.6

kpa

5.1

5.2

0.30

282

2160

(3024891) Influenza virus A+B Ag [Presence] in Specimen

139

914

1.54

5.45

1.3

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

195

1374

1.44

5.44

1.3

1.2

u/ml

0.3

1.3

2.07

115

(3024139) IgG subclass 3 [Mass/volume] in Serum

358

1.86

5.32

1.4

g/l

0.4

0.42

247

(3028192) IgG subclass 2 [Mass/volume] in Serum

358

1.86

5.32

1.4

g/l

2.5

2.9

1.34

247

(3027135) IgG subclass 1 [Mass/volume] in Serum

358

1.86

5.32

1.4

g/l

5.8

6.9

1.77

246

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

106

658

1.63

5.32

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

321

2470

1.32

5.23

2.6

2.4

au/ml

32.5

24.9

—

120

(3017446) Testosterone [Moles/volume] in Serum or Plasma

344

2673

1.31

5.22

2.3

2.2

nmol/l

12.8

0.01

293

2359

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

408

3243

1.28

5.22

2.5

2.3

ug/l

6.7

7.6

0.46

341

2855

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

133

876

1.53

5.19

1.6

—

(3000330) Specific gravity of Urine by Test strip

248

1839

1.37

5.16

4.0

3.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

159

1089

1.48

5.15

2.1

1.6

g/l

1.2

0.15

152

1026

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

159

1090

1.48

5.13

1.4

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

226

1653

1.39

5.12

2.8

2.5

0.7

0.6

0.16

220

1580

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

135

898

1.52

5.05

1.6

—

(3049717) Cytology report of Urine Cyto stain

199

1428

1.41

5.04

2.6

—

(3009343) pH of Capillary blood

300

2299

1.33

5.03

4.0

3.6

7.4

0.14

276

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

557

4614

1.24

5.01

4.6

4.5

31.5

32.6

1.53

342

3101

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

169

1179

1.45

5.00

4.0

3.4

mg/l

37.0

62.4

1.19

138

956

(3034860) Kappa light chains.free [Mass/volume] in Serum

169

1179

1.45

5.00

4.0

3.4

mg/l

53.3

58.0

0.13

138

957

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

376

2979

1.29

4.94

2.4

2.0

—

(4062490)

361

1.81

4.89

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

383

1.79

4.89

3.3

3.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

293

2251

1.32

4.84

1.4

1.3

au/ml

61.6

53.5

—

104

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

164

1145

1.45

4.84

3.9

3.4

ratio

3.8

2.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

183

2.14

4.74

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

198

1436

1.40

4.74

1.9

1.8

—

(3022313) Gas panel - Capillary blood

227

1685

1.37

4.72

4.0

3.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

288

2217

1.32

4.70

4.0

3.5

mmol/l

1.7

1.8

0.25

216

1647

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

228

1695

1.36

4.70

2.9

2.6

1.4

1.2

1.42

228

1681

(3048929) Epstein Barr virus Ab [Presence] in Serum

142

972

1.48

4.65

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

129

866

1.50

4.65

1.8

1.9

iu/l

3.2

4.8

1.71

302

(3017181) Myelocytes/100 leukocytes in Blood

391

3141

1.27

4.61

4.2

4.1

0.9

0.08

137

900

(3036489) Thrombin time

186

1342

1.40

4.60

1.8

2.1

23.2

21.5

0.90

168

1183

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

582

1.61

4.57

1.2

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

157

1101

1.44

4.55

1.8

—

(3044941) Cell count panel - Synovial fluid

591

1.60

4.54

1.6

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

437

3564

1.25

4.53

8.1

g/l

121.0

121.8

0.32

427

3433

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

338

2673

1.29

4.52

2.3

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

176

1262

1.41

4.51

2.9

3.1

u/ml

0.3

0.39

100

724

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

277

1.89

4.49

1.8

1.7

—

(3051651) Icteric interference index of Serum or Plasma

222

1.99

4.44

3.1

3.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

247

1877

1.33

4.43

2.6

2.8

e6/l

0.3

0.02

241

1827

(3022621) pH of Urine by Test strip

307

2406

1.30

4.41

2.8

3.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

465

1.67

4.37

2.1

titre

0.6

3.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

481

1.65

4.35

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

231

1745

1.34

4.32

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

483

1.65

4.28

2.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.96

4.27

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

415

1.70

4.26

1.5

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

493

1.63

4.21

5.5

7.0

mg/l

11.7

12.0

0.23

459

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

155

1102

1.42

4.20

1.9

2.3

90.1

90.7

0.11

148

1035

(3042631) Mycobacterium sp identified in Specimen

509

1.62

4.20

2.4

2.8

—

(3014271) Vancomycin [Susceptibility]

186

2.05

4.18

3.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

103

2.44

4.13

1.0

1.1

106.5

87.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

110

734

1.51

4.12

1.8

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

388

3160

1.25

4.09

2.9

ng/l

215.3

199.1

0.28

343

2879

(3021440) Promyelocytes/100 leukocytes in Blood

369

2992

1.25

4.04

4.2

4.1

0.1

1.83

128

836

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

259

1.86

4.02

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

259

1.86

4.02

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1323

12012

1.14

4.01

4.9

ug/l

2.4

3.5

1.23

1167

10778

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

117

2.32

4.00

1.4

1.2

g/l

0.3

0.34

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.94

4.00

1.5

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1.86

3.98

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

232

1.91

3.96

1.3

1.2

mmol/l

38.6

34.5

0.43

201

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

526

1.59

3.93

1.4

1.3

nmol/l

0.2

0.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

194

1450

1.35

3.92

4.3

3.8

mmol/l

25.0

24.8

0.23

169

1338

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

519

1.59

3.90

1.5

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

261

2038

1.30

3.89

9.4

10.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

181

1340

1.37

3.89

1.7

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.45

3.87

1.5

1.6

ug/l

0.3

0.4

1.32

(3004809) Band form neutrophils/100 leukocytes in Blood

633

1.53

3.83

3.8

3.2

1.3

1.4

0.21

482

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

463

3874

1.22

3.80

3.9

3.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

651

1.52

3.78

1.4

1.6

—

(3019150) Specific gravity of Urine by Refractometry

880

7791

1.16

3.77

4.3

4.2

kg/l

1.0

0.59

126

1179

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

287

1.79

3.76

1.1

—

27.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

3.75

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

130

916

1.43

3.74

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

174

2.02

3.73

1.3

1.1

iu/ml

2.7

4.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

288

1.78

3.72

1.3

1.4

promille

1.3

1.2

0.11

217

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

267

1.81

3.68

2.6

1.9

nmol/l

19.6

18.0

0.45

252

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

149

2.09

3.62

1.2

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1.80

3.59

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1.80

3.59

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1.80

3.59

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

405

1.64

3.59

4.0

3.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

349

2867

1.24

3.44

4.0

3.9

0.5

0.6

0.41

644

(3044927) Protein electrophoresis panel - Urine

379

1.64

3.43

1.4

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

179

1352

1.34

3.42

3.3

3.4

u/ml

365.7

3888.8

1.00

155

1145

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

197

1509

1.32

3.41

2.1

2.0

ug/l

1.1

2.3

1.74

167

1337

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.99

3.41

1.4

—

(3028433) Virus identified in Specimen by Culture

120

2.17

3.37

1.1

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

436

1.59

3.36

3.7

3.4

nmol/l

3.9

18.8

0.61

422

(40760888) Immunoglobulin light chains.free panel - Serum

123

877

1.41

3.35

4.0

3.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

155

2.01

3.29

1.0

1.1

u/ml

5.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

102

2.26

3.28

1.0

1.3

110.4

86.3

—

(3012501) Base excess in Blood by calculation

118

844

1.41

3.18

4.2

4.4

mmol/l

2.6

0.00

580

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

252

1.75

3.12

2.8

2.3

e6/l

779.7

674.9

0.45

112

(3024928) Oxygen saturation in Venous blood

109

772

1.42

3.11

2.9

2.8

—

(3003694) ABO and Rh group [Type] in Blood

1078

9800

1.13

3.10

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1079

9823

1.13

3.02

1.7

1.6

mmol/l

1.4

1.33

907

8243

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

481

1.53

3.00

1.6

1.4

—

(1002224) Polysomnography panel

185

1433

1.30

3.00

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

105

745

1.42

2.98

3.3

3.7

57.0

57.5

0.14

105

745

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

120

2.09

2.98

2.2

1.5

pmol/l

17.8

15.4

1.19

100

(3024522) Salmonella sp identified in Specimen by Organism specific culture

476

1.52

2.92

1.6

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

582

1.47

2.92

1.1

u/ml

4.7

1.6

0.60

228

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

360

1.59

2.83

2.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

384

1.57

2.82

4.4

3.2

57.7

58.3

0.08

243

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

163

1253

1.31

2.81

1.9

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

179

1.85

2.81

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

473

1.51

2.80

1.6

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

137

1028

1.34

2.80

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

103

739

1.40

2.77

1.8

1.9

pmol/l

179.9

202.2

1.27

698

(3025468) Yersinia sp identified in Specimen by Organism specific culture

466

1.51

2.77

1.6

1.4

—

(3017704) Immunofixation for Urine

202

1.79

2.76

1.8

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

203

1611

1.27

2.76

4.8

3.8

49.6

49.0

0.11

203

1589

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

475

1.50

2.75

1.0

1.1

g/l

1.5

0.13

429

(3023323) Follitropin [Units/volume] in Serum or Plasma

171

1330

1.30

2.72

1.4

iu/l

32.0

31.0

0.16

149

1140

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

248

1.70

2.71

1.4

1.3

u/ml

0.3

1.0

0.87

117

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

1034

1.34

2.70

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

471

1.49

2.65

1.8

2.2

mg/l

17.2

23.6

0.74

116

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

183

1.81

2.64

2.8

3.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

513

1.47

2.62

2.9

2.4

u/ml

350.1

654.7

0.22

491

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

177

1.81

2.59

3.7

4.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

338

1.57

2.56

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.36

2.55

1.3

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

443

1.50

2.54

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

208

1.74

2.53

3.1

2.7

38.0

39.9

0.21

(3005988) Vibrio sp identified in Specimen by Organism specific culture

469

1.48

2.50

1.6

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

121

909

1.34

2.49

5.3

4.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

233

1.68

2.45

1.6

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

145

1.87

2.41

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

145

1.87

2.41

1.9

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

356

3043

1.18

2.40

4.3

3.9

mmol/l

1.2

0.44

319

2667

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

360

1.53

2.40

1.3

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

683

1.38

2.40

1.3

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

153

1.84

2.37

1.3

2.2

163.4

154.0

0.22

142

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

228

1.67

2.36

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

468

1.46

2.34

1.6

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

283

1.60

2.33

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

147

1.84

2.32

1.9

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

133

1.88

2.30

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

261

1.62

2.29

3.5

2.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

246

1.63

2.27

1.8

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

341

1.53

2.26

1.3

1.4

e6/l

13255.9

86830.8

1.50

236

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

431

1.47

2.25

1.7

1.5

54.0

59.9

0.62

266

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

303

1.56

2.21

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

884

1.32

2.20

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

107

1.97

2.20

1.2

—

(3010421) pH of Blood

128

990

1.30

2.19

4.2

7.4

0.19

117

831

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1455

13667

1.10

2.18

4.4

3.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

2.18

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

2.24

2.17

1.1

—

(1761868) Lipid panel - Serum or Plasma

1168

12535

0.91

2.17

3.2

2.9

—

(3028707) Methadone [Presence] in Urine by Screen method

435

1.45

2.16

2.6

3.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

527

1.41

2.15

1.3

1.2

u/ml

4.2

4.8

0.15

220

(3047007) Chlamydophila sp Ab [Presence] in Serum

477

1.43

2.15

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1038

9601

1.11

2.14

4.6

4.1

estimate

0.0

1.28

335

3225

(21494815) CD4 cells/100 lymphocytes in Specimen

298

1.55

2.13

2.3

2.2

34.4

44.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

189

1.70

2.13

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

174

1.73

2.12

1.8

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

174

1.73

2.12

1.8

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.37

2.12

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

194

1587

1.23

2.10

2.1

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

488

1.42

2.09

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

1.72

2.09

2.9

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.14

2.08

1.2

1.3

—

(44813793)

229

1.62

2.07

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

137

1078

1.28

2.07

1.6

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

445

0.58

2.07

1.9

1.7

—

(4133840)

2.08

2.06

1.4

1.1

—

(3025159) Blasts/100 leukocytes in Blood

326

2806

1.17

2.06

4.3

4.2

0.0

0.3

1.03

699

(3003888) Timothy IgE Ab [Units/volume] in Serum

515

1.40

2.06

1.0

1.1

u/ml

7.1

4.5

0.61

258

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

660

1.36

2.05

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.33

2.04

1.7

1.8

ng/l

96.1

116.4

0.38

(3022806) Fractional oxyhemoglobin in Capillary blood

499

1.41

2.04

1.7

1.9

88.8

89.7

0.50

493

(3011412) CD3 cells [#/volume] in Blood

350

1.49

2.04

2.4

2.2

e9/l

1.0

1.1

0.81

206

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

254

1.58

2.03

1.9

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

106

809

1.32

2.02

2.3

2.2

g/l

128.0

128.7

0.09

573

(3045142) Bone marrow Pathology biopsy report

425

1.44

2.02

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.64

2.01

1.0

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

120

933

1.29

2.00

3.6

3.1

mmol/l

24.2

25.0

1.16

108

811

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

104

1.93

2.00

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

401

1.45

2.00

1.7

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

115

891

1.30

1.97

2.5

2.2

u/l

2946.5

4218.1

0.31

355

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

588

1.37

1.96

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.36

1.94

1.2

1.1

—

(44806118)

420

1.43

1.94

1.5

1.4

—

(44790048)

420

1.43

1.94

1.5

1.4

—

(44790047)

420

1.43

1.94

1.4

—

(44790049)

420

1.43

1.94

1.5

1.4

—

(3036603) Volume of Urine

234

1.59

1.92

1.5

2348.3

1941.6

0.54

(3051593) INR in Capillary blood by Coagulation assay

180

1.67

1.91

10.0

13.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

348

1.47

1.89

1.9

1.6

—

(3037121) Protein [Mass/volume] in Urine

157

1272

1.24

1.89

3.0

3.1

g/l

0.3

0.11

506

(3008401) Mugwort IgE Ab [Units/volume] in Serum

499

1.39

1.88

1.0

1.1

u/ml

1.5

1.4

0.05

206

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

116

909

1.28

1.85

1.5

1.3

miu/ml

216.2

213.7

0.03

394

(40768446) Kidney Pathology biopsy report

144

1.74

1.84

1.4

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

112

875

1.29

1.83

1.6

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

469

1.39

1.80

1.1

u/ml

6.2

2.0

—

116

(3019832) Treponema pallidum Ab [Presence] in Serum

288

2485

1.17

1.80

1.7

1.6

—

(3008037) Lactate [Moles/volume] in Venous blood

102

791

1.30

1.77

4.5

3.0

mmol/l

1.5

1.6

0.27

102

766

(3014599) Egg white IgE Ab [Units/volume] in Serum

154

1.69

1.75

1.0

u/ml

0.5

0.4

—

(1616796) Gas panel - Central venous blood

104

810

1.29

1.75

4.1

3.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

338

1.45

1.74

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

263

3051

0.85

1.74

1.3

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.23

1.73

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

439

1.39

1.73

3.3

2.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

217

1.57

1.73

6.4

6.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

178

1.63

1.72

1.3

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

186

1.62

1.71

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

186

1.62

1.71

1.9

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

186

1.62

1.71

1.9

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

186

1.62

1.71

1.9

1.7

—

(3011648) Oxygen content in Venous blood

290

1.49

1.71

2.3

2.1

10.8

11.2

0.20

290

(40758358) Immune stain study

3.85

1.71

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

639

1.32

1.69

1.3

1.2

u/ml

337.3

269.8

0.54

397

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

105

824

1.28

1.68

1.5

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

227

1.55

1.67

2.6

2.3

e9/l

0.2

0.30

199

(3048879) Bone marrow aspiration report

104

1.83

1.67

3.2

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

292

1.48

1.67

1.3

1.2

u/ml

11.2

46.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.16

1.66

1.5

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

157

1.66

1.65

1.1

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.93

1.64

1.0

1.1

u/ml

0.3

1.7

—

(3021901) Oxygen saturation in Capillary blood

660

1.31

1.63

2.9

2.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

366

0.60

1.63

1.8

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.57

1.61

1.0

—

(3020491) Glucose [Moles/volume] in Blood

278

1.48

1.61

1.7

1.9

mmol/l

7.0

6.8

0.12

184

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

295

1.46

1.60

1.0

1.1

mg/l

294.2

288.9

0.18

267

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

151

1.66

1.59

1.2

2.6

umol/l

90.3

160.0

0.99

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

238

1.52

1.59

2.5

2.2

e6/l

590.4

544.5

0.19

200

(3028271) Lactate [Moles/volume] in Capillary blood

593

1.32

1.59

1.7

1.9

mmol/l

1.6

1.7

0.16

579

(3007566) Smooth muscle Ab [Titer] in Serum

124

1001

1.25

1.59

1.2

titre

173.9

97.4

0.50

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

106

1.80

1.58

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

329

1.43

1.58

5.0

4.8

u/ml

19.2

59.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

542

1.33

1.57

1.2

u/ml

1.6

3.9

2.00

179

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

231

1.52

1.56

1.9

1.5

u/l

6.7

6.3

0.05

109

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

207

1.55

1.56

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

137

1121

1.23

1.56

1.6

iu/ml

0.2

6.1

0.58

233

(3016879) Cocaine [Presence] in Urine

115

923

1.25

1.55

2.1

2.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

264

1.48

1.55

1.8

2.0

15.7

13.6

0.34

107

(3035285) Chloride [Moles/volume] in Venous blood

450

1.36

1.53

3.3

2.4

mmol/l

105.4

105.3

0.03

441

(3041354) Potassium [Moles/volume] in Venous blood

450

1.36

1.53

3.3

2.4

mmol/l

4.1

0.14

441

(3001964) Herpes simplex virus Ag [Presence] in Specimen

100

1.80

1.52

1.3

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.34

1.52

1.0

1.2

—

(40768793) Breast Pathology biopsy report

104

828

1.26

1.51

1.5

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

261

2991

0.86

1.51

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

417

1.37

1.50

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

400

1.38

1.50

2.4

2.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

275

1.46

1.49

1.2

1.3

mmol/l

11.7

12.0

0.13

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

226

1.51

1.48

1.3

1.4

titre

58.3

60.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

317

1.42

1.48

1.6

1.8

umol/l

4.3

8.1

1.14

221

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

707

1.28

1.47

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

276

1.45

1.46

1.3

1.1

u/ml

2.2

3.5

—

(40765096) Chromosome analysis panel by Banding

117

1.71

1.44

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

718

1.27

1.44

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

586

1.30

1.43

1.5

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.79

1.42

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.79

1.42

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

1.85

1.40

1.7

1.9

e6/l

158.0

160.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.18

1.39

2.1

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

677

1.28

1.39

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

373

1.37

1.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

786

1.25

1.37

2.7

2.5

16.2

16.1

0.07

386

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.61

1.36

1.2

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

331

1.39

1.36

1.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

331

1.39

1.36

1.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

331

1.39

1.36

1.9

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

491

0.69

1.36

1.6

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.94

1.36

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

340

1.39

1.35

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

531

1.30

1.34

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.04

1.32

4.7

5.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

113

1.68

1.31

1.1

—

(3023410) Appearance of Cerebral spinal fluid

351

1.37

1.30

1.3

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.30

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

352

1.37

1.29

1.4

1.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

—

26.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

387

1.35

1.27

2.1

1.4

iu/ml

31.8

24.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.05

1.26

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

194

1.50

1.26

1.1

1.2

nmol/l

134.4

135.2

0.04

194

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

380

1.35

1.25

1.1

98.4

95.2

0.30

360

(1001926) Buprenorphine [Presence] in Urine by Screen method

779

1.24

1.23

2.3

2.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

163

1.54

1.22

1.6

1.7

nmol/l

1.9

7.6

1.24

137

(3028300) Cannabinoids [Presence] in Urine

121

1010

1.20

1.19

2.1

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.83

1.19

2.3

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

375

1.34

1.18

1.2

u/l

49.8

56.6

0.55

256

(21494434) Karyotype in Bone marrow

332

1.36

1.18

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

281

1.39

1.18

1.2

1.5

ug/l

2.1

4.1

1.47

242

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

350

1.35

1.17

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.93

1.17

1.5

1.4

—

(3035880) pH of Pleural fluid

198

1.47

1.16

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

120

1004

1.20

1.16

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

499

1.29

1.16

1.1

—

(3008898) HLA-B27 [Presence]

135

1142

1.19

1.16

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

1.67

1.16

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

190

1.48

1.16

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

110

1.64

1.15

1.2

g/l

41.6

39.1

—

(3019060) Gas panel - Arterial blood

281

2513

1.13

1.14

4.4

4.9

—

(3000764) Benzodiazepines [Presence] in Urine

119

998

1.20

1.13

2.1

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

734

1.23

1.13

1.7

1.9

nmol/l

0.9

0.8

0.53

620

(3005082) Progesterone [Moles/volume] in Serum or Plasma

103

1.65

1.12

1.2

1.3

nmol/l

31.0

29.3

0.09

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

511

1.28

1.11

1.6

1.4

—

(3017569) Oxygen content in Arterial blood

183

0.55

1.11

1.9

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

127

1.58

1.11

1.8

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

176

1529

1.16

1.10

4.9

5.5

1.7

1.6

0.27

166

1422

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

569

5286

1.09

1.10

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

566

1.26

1.09

1.2

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.38

1.09

1.2

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

160

1.50

1.09

1.0

1.1

u/ml

3.7

0.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.82

1.09

1.5

1.3

—

120.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1011

9606

1.07

1.08

4.3

4.2

22.1

21.7

0.36

455

4621

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.69

1.07

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

288

1.36

1.04

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.79

1.04

1.3

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

437

1.29

1.03

1.3

1.5

nmol/l

0.5

0.3

0.80

334

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

229

1.40

1.03

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.06

1.02

1.6

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.84

1.02

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.84

1.02

1.0

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

500

1.26

1.02

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

780

1.21

1.02

1.4

1.5

e6/l

7957.3

1116.9

0.50

634

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

780

1.21

1.02

1.3

1.4

e6/l

22.6

24.0

0.04

598

(3027944) Amphetamines [Presence] in Urine

117

991

1.19

1.02

2.2

2.3

—

(3011288) Drugs identified in Urine by Screen method

662

1.23

1.02

2.8

3.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

307

1.34

1.01

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

368

1.31

1.01

2.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

230

1.39

1.01

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

369

1.30

1.00

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

601

1.24

0.99

1.9

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

326

1.32

0.98

1.8

1.9

—

1.5

—

(4306422)

521

1.25

0.98

1.2

—

(3024263) Appearance of Synovial fluid

198

1.42

0.97

2.0

1.7

—

(3019174) dRVVT (LA screen)

1.95

0.97

1.7

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.85

0.96

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

740

1.21

0.96

3.4

3.1

nmol/l

0.7

0.8

2.39

562

(3007930) Methemoglobin/Hemoglobin.total in Blood

172

1512

1.14

0.95

5.0

5.6

0.9

0.21

165

1411

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

216

1.39

0.95

1.7

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

216

1.39

0.95

1.7

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

110

935

1.18

0.94

1.1

u/ml

1.5

5.4

2.08

103

(3028717) Thiamine [Mass/volume] in Blood

1.89

0.94

1.1

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

338

1.30

0.93

1.6

1.4

38.9

31.1

0.68

208

(3042517) Benzodiazepines panel - Urine

2.22

0.93

2.2

2.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

209

1.39

0.92

1.0

1.1

iu/ml

13.1

11.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.14

0.91

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

102

1.57

0.90

1.0

1.3

nmol/l

166.4

135.8

—

(3045424) Erythrocytes [Presence] in Urine

637

1.21

0.89

1.5

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

332

1.30

0.89

1.2

1.4

u/l

259.2

325.9

0.61

319

(40768441) Liver Pathology biopsy report

271

1.33

0.88

1.2

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.79

0.87

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

458

1.25

0.87

1.2

1.4

pmol/l

261.0

273.3

0.16

354

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

281

1.32

0.86

1.4

1.2

titre

174.0

138.4

0.16

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

522

1.23

0.86

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.82

0.85

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.82

0.85

1.1

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

104

889

1.17

0.85

1.3

mg/l

585.9

523.6

0.44

838

(44816559) Phosphatidylethanol [Mass/volume] in Blood

650

1.20

0.85

1.3

—

(40761536) Microorganisms panel - Urine sediment

335

3083

1.09

0.85

5.0

4.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.56

0.84

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

213

1.36

0.84

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.88

0.81

2.0

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

249

1.33

0.81

1.6

1.5

—

(4015189)

1.55

0.81

3.9

2.3

—

(4268621)

373

1.26

0.81

2.4

2.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

130

1.46

0.80

1.1

3.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.70

0.80

1.5

2.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

500

1.22

0.79

1.1

116.5

114.4

0.19

455

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.3

—

370.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

366

1.26

0.78

1.1

u/ml

1.2

3.5

1.80

143

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

140

1.43

0.76

2.1

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

1.77

0.76

1.8

1.2

—

(3042733) HLA Ab [Presence] in Serum

107

1.50

0.76

4.4

4.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

183

1.37

0.75

1.7

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

183

1.37

0.75

1.7

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

192

1.36

0.75

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

103

893

1.16

0.74

2.1

2.3

ug/min

48.1

103.9

2.43

555

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

102

1172

0.87

0.72

1.7

1.8

—

(3022475) Manganese [Moles/volume] in Blood

2.00

0.72

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.80

0.72

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

317

1.26

0.71

1.2

nmol/l

328.6

364.5

0.66

279

(1617658) Protocol used for examination of sentinel lymph nodes

287

0.73

0.71

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

410

0.78

0.70

2.2

5.8

mmol/l

6.7

7.4

0.95

343

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

727

6941

1.06

0.69

2.9

3.0

ug/l

0.7

0.8

1.86

474

4617

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

142

0.63

0.69

2.8

2.4

—

(3047189) Immunofixation for 24 hour Urine

195

1.34

0.69

2.5

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

592

1.19

0.69

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

200

1819

1.10

0.68

3.1

3.7

u/ml

36.8

63.6

1.06

194

1755

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

1.35

0.68

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.85

0.68

1.2

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.56

0.68

2.9

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

130

1154

1.13

0.68

3.9

4.0

mmol/l

3.9

0.03

118

1081

(3020891) Body temperature

167

1505

1.11

0.68

4.6

4.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.63

0.66

1.9

1.7

umol/l

35.3

43.7

—

(4146454)

411

1.22

0.66

3.0

2.7

—

(4198724)

119

1.43

0.66

1.5

3.4

—

(3001556) Androgen free Index in Serum or Plasma

1.79

0.66

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

111

1.44

0.65

2.4

1.4

ug/l

8.6

8.9

0.12

111

(3028308) Erythrocytes [#/volume] in Pleural fluid

394

1.22

0.65

1.5

1.4

e6/l

73616.5

82405.0

0.06

230

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.59

0.65

3.1

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

515

1.19

0.63

5.2

5.4

umol/l

346.5

362.2

0.42

454

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

225

1.29

0.63

1.0

1.1

nmol/l

0.2

7.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

379

1.22

0.61

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

987

9534

1.05

0.60

3.8

3.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

335

1.23

0.59

1.0

u/ml

0.4

—

(3045716) Anion gap in Serum or Plasma

186

0.70

0.59

1.5

2.2

mmol/l

8.4

9.3

—

147

(3029396) Erythrocyte agglutination [Presence] in Blood

1.51

0.58

1.6

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

1.46

0.58

1.7

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

595

1.16

0.57

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.67

0.56

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

265

1.25

0.56

1.1

1.4

pmol/l

82.1

169.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.46

0.56

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.46

0.56

1.6

—

(4212803)

1.62

0.55

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.62

0.55

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.62

0.55

1.5

1.3

nmol/l

68.3

4.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

248

1.25

0.55

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

570

1.16

0.54

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

116

1.38

0.54

3.6

2.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

155

1696

0.91

0.53

1.8

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

249

1.25

0.53

2.4

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

1.43

0.52

3.1

6.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

133

0.68

0.51

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

278

1.22

0.51

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.47

0.50

1.1

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

444

1.17

0.50

1.5

1.4

e6/l

2876.7

2078.0

0.29

325

(21494814) CD8 cells/100 lymphocytes in Specimen

153

1.31

0.50

1.9

2.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

622

1.14

0.50

1.7

1.2

u/l

49.2

36.1

0.22

535

(3014133) Dog dander IgE Ab [Units/volume] in Serum

400

1.18

0.48

1.1

u/ml

5.7

2.5

0.36

147

(3000012) Reticulocyte production index

181

1.27

0.48

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.49

0.47

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.49

0.47

3.3

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

183

1973

0.92

0.47

1.5

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.46

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

319

1.19

0.45

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

129

1.32

0.45

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.45

1.2

—

(3045788) Cell count panel - Pleural fluid

347

1.18

0.45

1.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

302

2860

1.06

0.43

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.43

0.42

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.65

0.42

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.56

0.42

2.0

4.0

—

(3020650) Glucose [Presence] in Urine

0.63

0.42

1.3

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.63

0.42

1.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

623

1.13

0.41

1.6

1.4

u/ml

121.1

115.2

0.07

114

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.38

0.41

1.9

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

195

0.77

0.41

2.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.52

0.41

1.2

1.1

—

2.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.52

0.41

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

0.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

454

1.15

0.41

1.3

mmol/l

8.0

7.4

0.55

339

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.39

0.40

1.6

1.8

—

101.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.31

0.39

1.1

1.0

—

(3044007) Cell count panel - Peritoneal fluid

106

0.66

0.39

3.6

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

403

3862

1.05

0.39

1.8

1.6

—

(3024932) HLA-DR beta [Type]

106

1.32

0.39

1.1

—

(3016228) CD19 cells/100 cells in Blood

160

1.25

0.38

1.9

2.0

8.6

8.5

0.01

153

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.38

0.38

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.39

0.38

2.4

2.6

u/field

0.2

0.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

197

1.22

0.37

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

145

1349

1.08

0.37

3.7

3.8

mmol/l

1.3

1.4

0.69

139

1328

(44806071)

1.35

0.37

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.65

0.35

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.64

0.35

9.0

8.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.43

0.35

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

123

0.73

0.35

1.7

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

794

1.10

0.35

2.5

3.0

umol/l

38.6

36.4

0.20

681

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

156

0.77

0.34

1.1

77.3

91.6

—

121

(3024471) HLA-A [Type]

109

1.29

0.33

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

228

1.19

0.33

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1031

0.92

0.33

1.6

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.67

0.32

12.0

8.0

—

(40768806) Pleura Pathology biopsy report

388

1.14

0.32

1.7

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.30

0.30

6.9

5.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.30

0.30

3.4

2.6

—

(40757373) Influenza virus identified in Isolate

1.31

0.30

1.4

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.27

0.30

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.27

0.30

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.27

0.30

1.1

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

194

1.19

0.29

1.5

1.8

—

9.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

430

0.88

0.29

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

573

1.10

0.29

1.1

iu/ml

24.4

978.7

0.54

139

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

0.74

0.29

1.0

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

794

0.92

0.28

3.5

3.6

mg/l

29.7

27.5

0.18

493

(3052592) Norovirus Ag [Presence] in Stool

1.25

0.27

1.4

1.5

—

(3006462) Nitrate [Presence] in Urine

177

1.19

0.27

4.5

3.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

168

1.19

0.27

1.3

64.5

67.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

702

1.08

0.26

1.5

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

150

1.20

0.26

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

253

1.15

0.26

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.70

0.26

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

394

0.89

0.26

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

367

1.12

0.26

1.1

—

21.9

—

(3015183) Erythrocyte sedimentation rate

169

1.18

0.25

1.2

—

(4094501)

109

1024

1.07

0.25

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

202

0.84

0.24

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

245

1.14

0.24

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

754

0.93

0.23

1.2

—

(3022689) Creatine [Moles/volume] in Urine

106

1.23

0.23

1.7

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

125

0.80

0.23

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.23

3.0

1.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.25

0.22

1.2

1.3

—

640.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.27

0.22

1.5

2.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.19

0.21

1.4

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

6.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(4027681)

201

1.15

0.21

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

201

1.15

0.21

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

192

1.15

0.20

1.0

1.1

u/l

65.7

84.2

0.87

145

(3026470) Cobalt [Mass/volume] in Blood

230

1.13

0.20

1.7

2.0

ug/l

2.4

3.2

0.46

205

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.20

0.0

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.20

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

674

1.07

0.20

3.4

3.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

250

0.88

0.20

1.6

1.5

—

67.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

176

0.85

0.19

1.2

—

(44806420)

1.21

0.19

2.3

2.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

193

1.14

0.19

1.0

1.1

u/l

26.7

26.5

0.01

140

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

203

1.13

0.19

1.0

1.1

ratio

1.2

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

245

2374

1.03

0.18

6.9

7.0

mmol/l

24.6

24.5

0.18

228

2215

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.13

0.18

3.7

13.4

mmol/l

11.7

6.0

—

(3012441) Differential panel - Pleural fluid

376

1.09

0.18

1.4

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

1.18

0.17

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.11

0.17

1.6

2.0

umol/l

16.5

16.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

253

1.11

0.16

1.1

1.0

ng/l

205.5

322.6

5.36

166

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

253

1.11

0.16

1.1

1.0

ng/l

786.5

700.7

0.52

162

(3025577) Chromium [Mass/volume] in Blood

225

1.11

0.16

1.8

2.1

ug/l

1.5

2.2

1.49

195

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.10

0.15

1.3

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

458

1.07

0.15

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

140

0.86

0.15

1.1

miu/ml

1086.9

1543.3

1.33

140

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

255

1.10

0.15

1.1

1.0

ng/l

25.1

44.6

4.98

164

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

791

1.05

0.14

1.6

1.5

pmol/l

100.6

196.1

2.02

774

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

223

0.90

0.14

1.2

1.1

—

(3034426) Prothrombin time (PT)

131

1.15

0.14

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

228

1.10

0.13

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

132

1.14

0.13

1.9

—

(3047181) Lactate [Moles/volume] in Blood

123

1188

1.04

0.13

6.3

6.7

mmol/l

1.3

0.09

111

1041

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

590

1.05

0.12

1.5

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

385

1.07

0.12

1.1

—

2.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

278

1.08

0.12

1.7

1.5

g/l

0.9

1.0

0.44

278

(4211845)

191

1.10

0.11

4.6

3.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.11

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

1.13

0.11

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

163

1.10

0.10

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

231

1.08

0.10

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

144

1.11

0.10

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

545

1.05

0.10

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

545

1.05

0.10

1.4

—

(3033799) Differential panel - Peritoneal fluid

114

0.88

0.09

2.7

2.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.06

0.09

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

812

1.04

0.09

3.2

3.4

u/ml

83.0

649.5

1.09

746

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

114

1109

1.03

0.09

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

547

1.04

0.09

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

134

0.90

0.08

1.2

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

298

0.94

0.08

2.1

u/field

3.8

2.1

—

119

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

548

1.04

0.08

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.06

0.08

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.82

0.07

1.3

3.0

u/l

924.8

2347.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

333

1.05

0.07

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.07

0.07

1.1

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.06

0.07

1.0

—

(4034850)

118

1205

0.98

0.06

9.9

9.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.11

0.06

1.1

1.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

105

0.86

0.06

1.3

1.5

46.1

23.1

—

(3000034) Microalbumin [Mass/volume] in Urine

355

0.96

0.06

4.2

2.9

mg/l

61.2

38.5

0.32

259

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

242

0.95

0.05

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

595

0.97

0.04

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

111

1.08

0.04

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.08

0.04

1.2

1.1

—

(3004451) EKG impression Narrative

190

1.05

0.04

1.4

1.3

—

(3016750) Collection duration of Urine

220

0.95

0.03

2.0

min

511.4

492.6

0.40

162

(4024509)

371

0.97

0.03

1.4

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

441

0.97

0.03

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

461

0.98

0.03

1.2

1.1

u/ml

1.4

2.9

1.87

195

(3050129) First trimester maternal screen panel - Serum or Plasma

648

1.02

0.03

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

122

1234

0.99

0.03

1.5

1.7

mg/l

2.3

3.8

1.51

884

(3023383) Lactate [Moles/volume] in Pleural fluid

113

1.06

0.01

1.4

mmol/l

2.2

3.4

1.27

102

(3009871) Measles virus Ab [Titer] in Serum

113

1.06

0.01

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

1.06

0.01

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.06

0.01

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.06

0.01

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.06

0.01

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

856

0.99

0.00

6.8

7.7

mmol/l

104.6

105.1

0.35

763

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

0.98

0.00

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

0.98

0.00

2.4

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

0.98

0.00

2.4

2.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

465

1.01

0.00

1.4

1.5

—

(3039000) Anion gap in Blood

855

0.99

0.00

6.8

7.7

mmol/l

11.0

11.3

0.42

762

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

104

0.96

0.00

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

104

0.96

0.00

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.03

0.00

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

103

0.97

0.00

1.3

1.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

117

1.03

0.00

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

207

1.01

0.00

1.0

1.1

u/l

1.0

1.1

—

109

(3047352) Trisomy 18 risk [Likelihood] in Fetus

454

0.99

0.00

1.4

—

(3004775) Volume in Urine collected for unspecified duration

293

0.99

0.00

1.9

2.2

739.1

625.8

0.92

193

(4281824)

377

1.01

0.00

1.2

—

(3005033) Fetal Nuchal fold Thickness US

451

1.00

0.00

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

144.5

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

3018.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

4.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.3

—

0.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

44.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.01

0.00

3.7

2.8

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.99

0.00

1.4

2.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MOUTH_PHARYNX and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MOUTH_PHARYNX	1.122 [1.02, 1.23]	0.016
Birth year	0.996 [0.99, 1.0]	0.365

During the follow-up period (1.1.1998 — 31.12.2019), 2155 out of 12804 females with CD2_BENIGN_MOUTH_PHARYNX died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MOUTH_PHARYNX	1.3 [1.18, 1.43]	< 0.001
Birth year	0.994 [0.98, 1.0]	0.204

During the follow-up period (1.1.1998 — 31.12.2019), 2523 out of 10970 males with CD2_BENIGN_MOUTH_PHARYNX died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MOUTH_PHARYNX.

N-year risk	Females	Males
1	0.094%	0.33%
5	0.624%	1.878%
10	1.662%	4.503%
15	3.1%	8.47%
20	5.655%	14.488%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MOUTH_PHARYNX – Benign neoplasm of mouth and pharynx

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm of mouth and pharynx

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints